KAAUH DRUG FORMULARY

Updated June 2015

Developed by:
Abdullatif Alokifi
Eman AlMutairi

Acknowledgment
Sincere thanks to those who contributed to the development and review of this formulary:
Ahlam Al-duhaish
Haifa Al-Rabiah
Khalid Al-Harbi
Lina Al-Ghamdy
Maram AlMutairi
Najla Alabdulkareem

Atheer Al-harbi
Haila Alrakaf
Lamya Al-Issa
Maliha Al-sufyan
Nouf Alsaban
Sara Alqahtani

Inquiries should be directed to:

Pharmaceutical Care Services
KAAUH-Pharmacy@pnu.edu.sa
011-8203021
011-8203029
From Sunday to Thursday, 7:30 a.m. to 4:30 a.m.

Table of Content
Introduction
Preface
How to use this Formulary
Summary of changes (Amendments, deletions)
Formulary, P&T Committee
Addition of New Medication to KAAUH Formulary
Request for non-formulary medication for a specific patient
Controlled Medicat List
Narcotic Medication List
High Alert Medications (HAMs) List
Look-Alike and Sound-Alike Medications
Concentrated Electrolytes
Adult Crash Cart Medication List
Pediatric Crash Cart Medication List
Emergency Box medication list
Drug Recall
The AHFS Pharmacologic-Therapeutic Classification
4:00 - Antihistamine Drugs
8:00 - Anti-infective Agents
10.00 - Antineoplastic Agents
12.00 - Autonomic Drugs

16:00 - Blood Derivatives

20:00 - Blood Formation, Coagulation, and Thrombosis
24:00 - Cardiovascular Drugs
28:00 - Central Nervous System Agents
36:00 - Diagnostic Agents
40.00 - Electrolytic, Caloric, and Water Balance
44.00 - Enzymes
48.00 - Respiratory Tract Agents
52:00 - Eye, Ear, Nose, and Throat (EENT) Preparation
56.00 - Gastrointestinal Drugs
64:00 - Heavy Metal Antagonists
68:00 - Hormones and Synthetic Substitutes
72:00 - Local Anesthetics
76:00 - Oxytocics
80:00 - Serums, Toxoids, and Vaccines
84:00 - Skin and Mucous Membrane Agents
86:00 - Smooth Muscle Relaxants
88:00 - Vitamins
92:00 - Miscellaneous Therapeutic Agents
94:00 Devices
96:00 Pharmaceutical Aids
Alphabetical Classification

Introduction:
KAAUH Formulary is a continually updated list of medications and related information,
representing the clinical judgment of physicians, pharmacists and other healthcare
professionals, used in the treatment and/or diagnosis of disease and promotion of health.
It should be evidence based, reflecting international guidelines, and cost effective to serve
the health interests of the local population.

The aim of developing a formulary for King Abdullah bin Abdulaziz University Hospital is to
serve as a guide for physicians, prescribers, and other health care professionals.

Preface:
Drugs are listed in KAAUH Formulary by Pharmacologic-Therapeutic Classification. The
American Hospital Formulary Service (AHFS) classification system was used in this
formulary. This classification system is one of the most recognized methods for systemic
classification of medications. Drugs are listed by generic name. Some brand names are
included as a reference to assist in product recognition.

How to use this Formulary:

There are two ways to find your drug within the formulary:
1 . By Pharm acologic-Therapeutic Classification
For example drugs used to treat a heart condition are listed under the category 24:00
Cardiovascular Drugs. If you know what your drug is used for, look for the category
name in the table of content, then look under the category name for your drug.
2 . By Alphabetical list
If you are not sure what category to look under, you should look for your drug in the
Alphabetical list.

Formulary
A formulary is a continually updated list of medications and related information,
representing the clinical judgment of physicians, pharmacists, and other experts in the
diagnosis, prophylaxis, or treatment of disease and promotion of health. A formulary
includes, but is not limited to, a list of medications and medication-associated products or
devices, medication-use policies, important ancillary drug information, decision-support
tools, and organizational guidelines.

P&T Committee
The P&T committee is responsible for managing the formulary system. It is composed of
actively practicing physicians, other prescribers, pharmacists, nurses, administrators,
quality improvement managers, and other health care professionals and staff who
participate in the medication-use process.
The P&T committee should be responsible for:
Overseeing policies and procedures related to all aspects of medication use.
To the medical staff as a whole.
Medication-use evaluation (MUE).
Adverse-drug-event monitoring and reporting.
Medication-error prevention.
Development of clinical care plans and guidelines.

Addition of New Medication to KAAUH

Formulary
Replacement of existing drugs and superiority over existing drugs are two important areas
for Committee consideration. In order to control the growth of the formulary, it is preferred
that each addition be balanced by a deletion when practical. In any case, the Committee
must be provided with a published scientific journal article (not an advertisement)
demonstrating the efficacy of the new drug.
Restricted use of a drug is possible if it is felt that a drug should only be used by certain
members of the Medical Staff. This would mean that Pharmacy would not honor orders for
the drug by non-approved physicians.
Use rate of the new drug is essential to insure that reasonable quantities to insure both an
adequate supply for regular, sustained use as well as to prevent ordering an excessive
quantity that will never be used. Even though a drug is accepted for addition to the
Formulary, it will not be ordered until this information is provided in a suitable form.
The requesting physician should get the signatures of his Department Head before
submitting the completed form to pharmacy and therapeutic coordinator .The requesting
physician will be notified of the date and time of the Committee meeting to consider the
request and may be invited to attend to lend support.

Evaluating Medications for Inclusion in the

Formulary
The P&T committee should use a structured, evidence-based process in the evaluation of
medications for formulary consideration. The P&T committee should be provided with
information that reflects a thorough, accurate, and unbiased review and analysis of the
evidence available in the scientific literature. The evaluation process should encourage
objective consideration of clinical and care delivery information, facilitate communication,
foster positive patient outcomes, and support safe and effective medication ordering,
dispensing, administration, and monitoring. Decisions made by the P&T committee should
support improved patient care outcomes across the continuum of care.

Pharmacy and Therapeutics Committee

(Please read the instructions on the reverse side before filling the form)

Generic Name:____________________________________________________________
Trade Name :_____________________________________________________________
Dosage Form(s):____________________________________ Strength(s):_____________
Manufacturer (if known):____________________________________________________
Pharmacological Classification: Class:________________ Sub Class: ________________
Therapeutic Use(s):
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
What drugs, currently in the formulary, will be replaced?___________________________
How is requested drug superior to existing formulary drugs? ________________________
_________________________________________________________________________
_________________________________________________________________________
Should this drug be restricted to use by certain members of the Medical Staff?
If so, whom and why?
__________________________________________________________________________
__________________________________________________________________________
What will be the anticipated use rate if this drug is added to the formulary?:
_________________________________________________________________________
_________________________________________________________________________
=================================================================
REQUESTED BY: Name: ___________________________ Specialty:________________
Signature: ___________________________Date: _________________
APPROVED BY: Department Head: ___________________________________________
Signature: ____________________________ Date: _________________
==================================================================
PHARMACY USE ONLY: Registration/Availability Status/ Drug Evaluation:___________
Price: ______________________________________________
==================================================================
COMMITTEE ACTION: APPROVED:_____NOT APPROVED_______Date:_________
Requestor notified of action on (date): ___________________________________________

P & T Committee Chairmans Signature

INSTRUCTIONS FOR COMPLETION OF THE FORM

1. Formulary addition / deletion request form is to be completed by requester when
requesting the addition of a medication to the formulary.
2. The form must be filled in legibly in ink, preferably typed, by the physician
3. Replacement of existing drugs and superiority over existing drugs are two important areas for
Committee consideration. In order to control the growth of the formulary, it is preferred that
each addition be balanced by a deletion when practical. In any case, the Committee must be
provided with a published scientific journal article (not an advertisement) demonstrating the
efficacy of the new drug.
4. Restricted use of a drug is possible if it is felt that a drug should only be used by certain
members of the Medical Staff. This would mean that Pharmacy would not honor orders for the
drug by non-approved physicians.
5. Use rate of the new drug is essential to insure that reasonable quantities to insure both an
adequate supply for regular, sustained use as well as to prevent ordering an excessive quantity
that will never be used. This information must be in some form that can be readily used to
arrive at the quantity to be ordered. A statement such as two ampoules per patient visit and ten
patients per month is necessary. Even though a drug is accepted for addition to the Formulary,
it will not be ordered until this information is provided in a suitable form.
6. The requesting physician should get the signatures of his Department Head before
submitting the completed form to pharmacy and therapeutic coordinator . The requesting physician
will be notified of the date and time of the Committee meeting to consider the request and may
be invited to attend to lend support.
7. Formulary addition / deletion requests should have non-company sponsored literature, and
a summary of the literature attached for members review.
8. The requestor will also be notified of the Committees action and will be notified when the
medication is actually on hand ready to be used.

Requesting a Non-Formulary Medication

for a specific patient
Non-formulary medications shall not be dispensed by the pharmacy department
unless the item is not readily available in the community and only obtained for inhouse patients if a similar item or combination of items is not presently on the
formulary. Non-formulary medications may only be requested by the attending
physician, utilizing the "Request for non- formulary medication for a specific
patinets, form shall be reviewed by Drug Information pharmacist and approved
by the Director of pharmacy.
!

PHARMACEUTICAL CARE DEPARTMENT

REQUEST FOR NON-FORMULARY

MEDICATION FOR A SPECIFIC PATIENT

Urgent

Non-Urgent

Inpatient

Outpatient

Patient Name:
MRN:
Patient Age

Date of Request

Patient Weight

Please read the instructions on the next page before filling the form

I. Drug Related Information

Generic Name

Brand Name

Dosage Form

Strength

Frequency

Period of Treatment

Justification for the Request:

Requested By:
Physician Name

Specialty

Signature

Ext. No.

Mobile No.

Date

Time

II. Pharmacy Use Only:

Received By Pharmacist:

Date

Section:

Signature

Bleep/Ext. No.

III. Director of Pharmacy / Drug Information Pharmacist:

Approved

Time

Disapproved

Comment:

Requester Notified of Action on (Date):

Kindly complete this form and submit it to Pharmaceutical Care Department

PHARMACEUTICAL CARE DEPARTMENT

INSTRUCTIONS AND GENERAL INFORMATION

1. Non-Formulary request is to be completed by Physician when requesting a specific medication
for a specific. (This is not a request for addition to the formulary)
2. Non-Formulary request must include; complete review of patient history, scientific justification,
submission of the treatment protocol, supporting literature, and completed SFDA justification
form for non-registered items.
3. Only ORIGINAL Non-Formulary Request will be accepted and processed for drug evaluation.
4. The form must be filled out LEGIBLY by the requesting prescriber (one patient per form).
5. The Director of Pharmacy / Drug Information Pharmacist will evaluate the request and provide
the medication which will take maximum 10 working days from the date of receiving the
request.
6. For urgent request, the drug will be available within 24 hours or less according to the availability
of the drug.
7. For urgent requests consider, if the drug is a life-threatening agent or a Patient Owned
Medication (POM) that is out of stock and the patient cannot discontinue the medication
suddenly, or other serious condition.
8. For Patient Own Medication, the prescriber will request it as Non-Formulary Request which will
be provided within 5 days, if it is applicable.
9. Consultants are reminded to request special medications only as a last resort when there is no
alternative medication in the formulary.
10. The Medications requested through this form will be dispensed only to those patients for whom
they have been requested. (Medications WILL NOT be dispensed to other patients even when
being treated by the requesting physician).
11. Requesting Physician will be notified when the medication is available.
12. For unclaimed out-patient, the expiry date for the request is one month from its date of approval.

Controlled Medication
Item #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40

Generic Name
Diazepam
Midazolam
Midazolam
Ethanol
Pentobarbital
Pentobarbital
Phenobarbital
Alprazolam
Clonazepam
Clonazepam
Diazepam
Diazepam
Diazepam
Lorazepam
Lorazepam
Lorazepam
Methylphenidate
Methylphenidate
Methylphenidate
Phenobarbital
Phenobarbital
Phenobarbital
Thiopental
Nalbuphine
Benzhexol
Benzhexol
Clobazam
Ephedrine
Ketamine
Chlordiazepoxide
Chloral Hydrate
Chloral Hydrate
Zolpidem
Hydroxyzine
Phenobarbital
Pentobarbital
Alprazolam
Clonazepam
Ephedrine
Phenobarbital

Conc.
5 mg
5 mg
5 mg
5 mg
3 mg
4 mg
3 mg
0.5 mg
2 mg
0.5 mg
10 mg
5 mg
5 mg
1 mg
2 mg
2 mg
18 mg
36 mg
10 mg
100 mg
200 mg
60 mg
500 mg
20 mg
2 mg
5 mg
10 mg
50 mg
500 mg
5 mg
40 mg
100 mg
10 mg
10 mg
10 mg
30 mg
0.25 mg
2.5 mg
30 mg
60 mg

Volume
2ml
3ml
10ml
5ml
500ml
473ml
100ml
------0ml
--0ml
--1ml
----------1ml
1ml
1ml
1ml
------1ml
10ml
--500ml
500ml
----------10ml
1ml
---

Dosage form
Ampoule
Ampoule
Ampoule
Ampoule
Bottle
Bottle
Bottle
Tablet
Tablet
Tablet
Rectal Tube
Tablet
Rectal Tube
Tablet
Ampoule
Tablet
Tablet
Tablet
Tablet
Tablet
Ampoule
Ampoule
VIAL
Ampoule
Tablet
Tablet
Tablet
Ampoule
Ampoule
Tablet
Bottle
Bottle
Tablet
Tablet
Tablet
Tablet
Tablet
Ampoule
Ampoule
Tablet

Narcotic Medication:
Item #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

Generic Name
Fentanyl
Fentanyl
Fentanyl
Fentanyl
Fentanyl
Morphine
Morphine
Pethidine
Pethidine
Tramadol
Tramadol
Tramadol
Alfentanil
Codeine
Oxycodone
Remifentanil
Remifentanil
Sufentanil
Morphine
Morphine
Methadone
Tramadol

Conc.
0.05 mg
0.05 mg
4.2 mg
8.4 mg
16.8 mg
10 mg
2 mg
50 mg
50 mg
50 mg
50 mg
100 mg
0.5 mg
30 mg
5 mg
2 mg
5 mg
0.05 mg
10 mg
30 mg
5 mg
100 mg

Volume
2ml
10ml
------1ml
500ml
2ml
1ml
2ml
----2ml
----1ml
1ml
2ml
---------

Dosage form
Ampoule
Ampoule
Patch
Patch
Patch
Ampoule
Bottle
Ampoule
Ampoule
Ampoule
Capsule
Capsule
Ampoule
Tablet
Tablet
VIAL
VIAL
Ampoule
Tablet
Tablet
Tablet
Suppository

High Alert Medications (HAMs) List

Adrenergic Agonists (IV)
Epinephrine
Phenylephrine
Ephedrine
Isoproterenol
Norepinephrine
Adrenergic Antagonists (IV)
Propranolol
Metoprolol
Esmolol
Verapamil
Labetalol
Atenolol
Anesthetic Agents (General, inhaled and IV)
Propofol
Ketamine
Desflurane
Sevoflurane
Etomidate
Antiarrhythmics
Procainamide (IV)
Quinidine (PO)
Lidocaine (IV)
Phenytoin (PO, IV)
Amiodarone (IV)
Bretylium
Adenosine (IV)
Antithrombotic Agents
Warfarin (PO)
Enoxaparin (SC)
Heparin (IV)
Alteplase (IV)
Streptokinase (IV)
Chemotherapeutic Agents
Methotrexate (PO, IV)
Hydroxyurea (PO)
Azathioprine (PO)
Interferon beta 1a
Interferon beta 1b
Epidural or intrathecal medications
Bupivacaine
Bupivacaine Heavy
Oral Hypoglycemics
Metformin (PO)
Gliclazide MR (PO)
Glimepiride (PO)
Glibenclamide (PO)
Pioglitazone (PO)
Acarbose (PO)
Inotropic Medications
Milrinone (IV)
Digoxin (PO, IV)
DOPamine (IV)
DOBUTamine (IV)
Phentolamine (IV)
Moderate sedation agents
Midazolam (IV)
Chloral Hydrate (PO)
Ketamine (IV, IM)
Narcotics/Opioids
Fentanyl
Pethidine
Morphine
Tramadol

Cont.
Cont. High
High Alert
Alert Medications
Medications (HAMs)
(HAMs) List
List
Neuromuscular Blockers (IV)
Atracurium
Pancronium
Electrolytes (IV)
Potassium Chloride 2 mEq/mL or higher
concentration
Potassium Phosphate 3 mmol/mL or
higher conc
Potassium Acetate 2 mEq/mL or higher
concentration
Magnesium Sulfate, all concentrations
Vasodilators
Hydralazine (PO, IV)
Nitroprusside (IV)
General Groups
ALL Chemotherapeutic Agents (IV & Oral)
ALL Opiates & Narcotics (All routes)
ALL Intrathecal or Epidural Agents
ALL oral hypoglycemics
Miscellaneous Drugs
Dextrose 50% (IV)
Insulin (All routes)
Promethazine (IV)
Dextrose 50% (IV)
carBAMazepine

Succinylcholine
Rocuronium
Sodium Chloride 3% or higher concentration
Sodium Acetate 2 mEq/mL or higher concentration
Sodium Phosphate 3 mmol/mL or higher
concentration

Nitroglycerin (IV, PO)

Anesthetic Agents intravenous, inhaled and general

Dialysis Solutions (Peritoneal & Hemodialysis)
Cardioplegic Solutions

Oxytocin (IV)
Vasopressin (IV)
Total Parenteral Nutrition (TPN)
Liposomal forms of drugs
Sterile water for injection, inhalation, and irrigation
in containers of 100 mL or greater

Look-Alike and Sound-Alike Medications

A list of Look-Alike, Sound-Alike Medications is identified, maintained and reviewed
annually.Tallman lettering labels must be used for all Look-Alike, Sound-Alike Medications
to ensure medication safety. All Look-Alike, Sound-Alike Medications should be stored in an
individual containers with orange labels and separated from one another. All staff involved
in the medication process shall be educated on look-alike sound-alike medications.
Drug Name

Confused Drug Name

acetaZOLAMIDE

acetoHEXAMIDE

ALPRAZolam

LORazepam
MIDAZOLam
CLONAzepam
DIAZEPam

Concentrated Electrolytes
KAAUH must maintain patient safety measures to reduce the risk of errors related to the
medication use process, in regard to concentrated electrolytes. As concentrated
electrolytes are High Alert Medications, the safeguards outlined in the APP High Alert
Medication Guidelines are applicable (e.g.. Independent Double Checking, Medication
Segregation, etc).

Adult Crash Cart Medication List

Medications
Adenosine 3mg/ml ( 2ml) vial
Amiodarone 50 mg/ml ampoule ( 3ml)
Atropine 0.5mg premixed syringe ( 0.1mg/ml) (5ml)
Calcium chloride 10% premixed syringe (100gm/ml) ( 10ml)
Dextrose 50% vial ( 50ml)
Dopamine 400mg/250ml D5W premixed bag
Epinephrine 1:10000 (10ml) (premixed)
Epinephrine 1mg ampule
Lidocaine 2% premixed syringe (20mg/ml) ( 5ml)
Magnesium sulfate 50% ampoule
Nor epinephrine 1mg/ ml ampoule ( 4ml)
Sodium bicarbonate 8.4% premixed syringe ( 50ml)
Sodium chloride 0.9% 10 ml ampule
Vasopressin 20 Unit /ml vial ( 1ml )
Procainamide 100mg /ml ampoule ( 10ml)

Pediatric Crash Cart Medication List

Medications
Adenosine 3mg/ml ( 2ml) vial
Amiodarone 50 mg/ml ampoule ( 3ml)
Atropine 0.5mg premixed syringe ( 0.1mg/ml) (5ml)
Calcium chloride 10% premixed syringe (100gm/ml) ( 10ml)
Dextrose 50% vial ( 50ml)
Dopamine 400mg/250ml D5W premixed bag
Epinephrine 1:10000 (10ml) (premixed)
Epinephrine 1mg ampule
Lidocaine 2% premixed syringe (20mg/ml) ( 5ml)
Magnesium sulfate 50% ampoule
Nor epinephrine 1mg/ ml ampoule ( 4ml)
Sodium bicarbonate 8.4% vial ( 50ml)
Water for Injection (10ml )
Procainamide 100mg /ml ampoule ( 10ml)
Sodium chloride 0.9% 10 ml ampule
Naloxone 0.4mg/ml, 1ml ampoule

Emergency Box medication list

Medications
Atropine 0.5mg premixed syringe ( 0.5mg/5ml)
Sodium bicarbonate 8.4% vial ( 50ml)
Procainamide 1000mg /10ml ampoule
Naloxone 0.4mg/ml ampoule
Adenosine 6mg/2ml vial
Sterile water for injection 10ml
Amiodarone 150 mg/3ml ampoule
Calcium chloride 10% premixed syringe (1000mg/10ml)
Calcium gluconate 10% 10ml
Dextrose 50% vial ( 50ml)
Dopamine 400mg/250ml D5W premixed bag
Dobutamine Hcl 250mg/10ml
Epinephrine 1:10000 (1mg/10ml) (premixed)
Epinephrine 1mg/1ml ampule
Lidocaine 2% premixed syringe (100mg/5ml)
Magnesium sulfate 50% ampoule
Nor-epinephrine 4mg/ 4ml ampoule
Phenytoin 250mg IV (5ml) Vial
Digoxin 0.5mg/2ml I.V Injection
Furosemide 20mg/2ml ampule
Sodium chloride 0.9% 10 ml ampule
Vasopressin 20 Unit /ml vial
Verapamil 5mg/2ml injection
Diphenhydramine 50mg/1ml vial
Propranolol 1mg/1ml I.V Vial
Dextrose 10% 500ml IV in bottle
Flumazenil injection 0.5mg/5ml
Hydrocortisone 100mg I.V Ampoule
Normal saline 0.9% 500ml bag
Refrigerated
Isoproterenol Hcl 1:5000 (0.2mg/1ml) Ampoule
Glucagon 1mg ( 1unit) vial+ solvent in prefilled syringe

Drug Recall
Drug Recall: is the process by which medication declared contaminated, mislabeled or
dangerous by the manufacturers, national, international drug control body, is retrieved
from various storage and dispensing areas of the hospital both inpatient and ambulatory
care areas. There are three classes in which recalled are placed relative to its potential
harm. The recalled classes are as follows:
C lass I: This recall is for dangerous or defective products that could cause serious
health problems or death. This class is the most serious and requires immediate
action. You should remove the product(s) from service.
C lass II: This recall class is for products that might cause a temporary health
problem, or pose only a slight threat of a serious nature. You should identify and
take corrective action regarding the product(s).
C lass III: This recall class is for product(s) that are unlikely to cause any adverse
health reaction, but that are in violation of SFDA or equivalent regulatory agency
regulations. This class requires identifying the product(s) and recognizing its
potential harm

When a recall or discontinuation notice is received from FDA, SFDA, Manufacturer or any
equivalent regulatory agency, the drug(s) in question must immediately be removed from
all storage areas to ensure that the drug(s) is/are not available for use.
Prescriptions must be checked to determine if any prescription has been dispensed with
the lot number in question. The medical staff are notified through the Pharmaceutical Care
department that a recall notice has been received for a particular drug.

Reporting of Adverse Drug Reaction (ADR)

Adverse Drug Reaction and Medication Errors can be reported through our Hospital
medication safety program (MSP)
KAAUH-MSP@pnu.edu.sa

The AHFS Pharmacologic-Therapeutic

Classification
Was developed and is maintained by the American Society of Health-System Pharmacists
(ASHP). ASHP is the national professional association that represents pharmacists who
practice in inpatient, outpatient, home-care, and long-term-care settings. ASHP has a long
history of fostering evidence-based medication use as well as patient medication safety.
The following table lists the AHFS Classification. All marketed drug products fall under one
or more of these classifications:
AHFS Class Number
4:00
8:00
10:00
12:00
16:00
20:00
24:00
26:00
28:00
32:00
34:00
36:00
38:00
40:00
44:00
48:00
52:00
56:00
60:00
64:00
68:00
72:00
76:00
78:00
80:00
84:00
86:00
88:00
92:00
94:00
96:00

AHFS Class Description

Antihistamine Drugs
Anti-infective Agents
Antineoplastic Agents
Autonomic Drugs
Blood Derivatives
Blood Formation, Coagulation, and Thrombosis Agents
Cardiovascular Drugs
Cellular Therapy
Central Nervous System Agents
Contraceptives (foams, devices)
Dental Agents
Diagnostic Agents
Disinfectants (for agents used on objects other than skin)
Electrolytic, Caloric, and Water Balance
Enzymes
Respiratory Tract Agents
Eye, Ear, Nose, and Throat (EENT) Preparations
Gastrointestinal Drugs
Gold Compounds
Heavy Metal Antagonists
Hormones and Synthetic Substitutes
Local Anesthetics
Oxytocics
Radioactive Agents
Serums, Toxoids, and Vaccines
Skin and Mucous Membrane Agents
Smooth Muscle Relaxants
Vitamins
Miscellaneous Therapeutic Agents
Devices
Pharmaceutical Aids

KAAUH DRUG FORMULARY

By AHFS PHARMACOLOGIC/THERAPEUTIC CLASSES

Updated June 2015

4:00 - Antihistamine Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

Syrup

LASA

4:04 - First Generation Antihistamines

4:04.04 Ethanolamine Derivatives

DiphenhydrAMINE, Ammonium 14MG, 135MG,

1.1MG
chloride, Menthol
DiphenhydrAMINE, Menthol

7MG, 0.55MG

Syrup

DiphenhydrAMINE

50MG/ML, 1ML

Injection

25MG

Capsule

25MG/ML, 2ML

Injection

LASA

4:04.12 Phenothiazine Derivatives

Promethazine

4:08 - Seconed Generation Antihistamines

Loratidine

Loratadine, Pseudoephedrine
Dimethindene Maleate

1 mg / ml

Syrup

10 MG

Tablet

5MG, 120MG

Tablet
Gel
Oral Drops

HAM

8:00 - Anti-infective Agents

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

200mg

Tablet

AUR

400mg

Tablet

AUR

100MG

Tablet

AUR

Amikacin

500MG/2ML

Injection

Gentamicin

80MG/2ML

Ampule

LASA

LASA

8:08 Anthelmintics
Albendazole

Mebendazole

8:12 - Antibacterials
8:12.02 - Aminoglycosides

8:12.06 - Cephalosporins
8:12.06.04 - First Generation Cephalosporins

CeFAZolin Sodium

1 GM

Vial

Cephalexin

250 MG/5ML

Suspension

8:12.06.08 - Second Generation Cephalosporins

Cefuroxime

125MG/5ML

Suspension

250MG/5ML

Suspension

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

Cefuroxime Axetil

250 MG

Tablet

Cefuroxime Axetil

500 MG

Tablet

STATUS

8:12.06.12 - Third Generation Cephalosporins

Cefotaxime

500MG

Vial

CefTAZidime Injection

1 GM

Vial

LASA

CefTRIAXone

1 GM

Vial

LASA

1 GM

Vial

AUR

1 GM

Injection

500 MG

Injection

500 MG

Vial

0.5%,10ML

Eye Drops

1%

Eye
Ointment

8:12.06.16 Fourth Generation Cephalosporins

Cefepime

8:12.07 - Miscellaneous -Lactams

8:12.07.08 - Carbapenems

Meropenem

Imipenem and Cilastatin

8.12.08 - Chloramphenicol

Chloramphenicol

AUR

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

250 MG

Tablet

0.50% 3.5G

Eye
Ointment
Suspension

8:12.12 - Macrolides
8:12.12.04 - Erythromycins

Erythromycin

Erythromycin ethylsuccinate

200 MG BASE/5
ML 100 ML

8:12.12.92 - Other Macrolides

Azithromycin

200 MG/5 ML,

15 ML
250 MG

Suspension

500 MG

film coated
Tablet
Vial

125MG/5ML

Suspension

250 MG

Tablet

500 MG

Tablet

Penicillin G

1,000,000 I.U.

Injection

Penicillin Phenoxymethyl
potassium

250 MG/5 ML IN
100 ML

Suspension

Clarithromycin

8:12.16 - Penicillins
8:12.16.04 - Natural Penicillins

STATUS

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

8:12.16.12 - Penicillinase-resistant Penicillins

250 MG

Vial

250MG

Capsule

125MG/5ML

Syrup

250MG

Capsule

250MG/5ML

Suspension

500 MG

Capsule

1GM

Injection

250MG

Injection

400MG/ 57MG
per 5ML

Suspension

250MG/125MG

Tablet

500MG/100MG

Vial

875 MG, 125MG

Tablet

Amoxicillin, pot. Clavulanate

500MG/125MG

Tablet

Amoxicillin, Clavulanic acid as

potassium

125MG+31.25
MG/5ML

Suspension

Cloxacillin or Flucloxacillin

8:12.16.08 - Aminopenicillins

Amoxicillin

Ampicillin

Amoxicillin, Clavulanic acid

8:12.16.16 - Extended-spectrum Penicillins

4 GM, 500 MG
Piperacillin Sodium,
Tazobactam Sodium (Tazocin)

Vial

AUR

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

Amoxicillin

250MG

Capsule

250MG/5ML

Suspension

500 MG

Capsule

1GM

Injection

250MG

Injection

400MG/ 57MG
per 5ML

Suspension

250MG/125MG

Tablet

500MG/100MG

Vial

875 MG, 125MG

Tablet

Amoxicillin, pot. Clavulanate

500MG/125MG

Tablet

Amoxicillin, Clavulanic acid as

potassium

125MG+31.25
MG/5ML

Suspension

Ampicillin

Amoxicillin, Clavulanic acid

4 GM, 500 MG
Piperacillin Sodium,
Tazobactam Sodium (Tazocin)

Vial

8:12.18 - Quinolones

Ciprofloxacin

Levofloxacin

200MG/100ML
250MG

Solution for
infusion
Tablet

500MG

Tablet

500MG/100ML

Injection

STATUS

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

Moxifloxacin

400MG

Tablet

0.50%

Eye Drops

400MG

Injection

800/160MG

Tablet

400MG/80MG

Ampoule

Co-trimoxazole Paediatric

40 MG,200
MG/5ML, 50ML

Suspension

SulfaSALAzine

500MG

Tablet

100MG

Tablet

50MG

Vial

Clindamycin Injection

300 MG/2 ML

Ampoule

Clindamycin Injection

600 MG/4 ML

Ampoule

Clindamycin

150 MG

Capsule

STATUS

AUR

8:12.20 - Sulfonamides

Co-trimoxazole

LASA

8:12.24 Tetracyclines

Doxycycline

8:12.24.12 Glycylcyclines

Tigecycline

8:12.28 - Antibacterials, Miscellaneous

8:12.28.20 Lincomycins

AUR

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

Clindamycin

1%

Topical
Solution
Vaginal
Cream

2% 40G

STATUS

8:12.28.16 Glycopeptides
1G

Vial

500 MG

Vial

2MG/ML,
300ML

Injection

150mg

Vial

150MG

Capsule

300MG

Capsule

Rifampicin , Isoniazid

300MG/150MG

Tablet

Rifampicin

300MG

Vial

Vancomycin HCL

8:12.28.24 Oxazolidinones

Linezolid

8:12.28.28 Polymyxins

Colistine

8:12.28.30 Rifamycins

Rifampicin

AUR

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

150MG

Capsule

2MG/ML

Vial

10MG/ML

Suspension

100MG

Capsule

10MG/ML 25ML

Injection

10MG/ML

Oral
Solution
Shampoo

STATUS

8:14 - Antifungals
8:14.08 - Azoles

Fluconazole

Itraconazole

Ketoconazole

2%, 120ML
2% (20MG/GM)
30GM

Cream

200MG

Tablet

50 MG

Vial

AUR

70 MG

Vial

AUR

Amphotericin B

50 MG

Injection

LASA

Amphotericin-B Liposomal

50 Mg

Injection

AUR, LASA

Voriconazole

8:14.16 Echinocandins

Caspofungin

8:14.28 - Polyenes

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

Nystatin

15GRAMS

Cream

LASA

15GRAMS

Ointment

LASA

125MG

Tablet

125 MG/ 120ML

Syrup

Ethambutol

400MG

Tablet

Isoniazid

100MG

Tablet

300MG

Tablet

500MG

Tablet

8:14.92 - Antifungals, Miscellaneous

Griseofulvin

8:16 - Antimycobacterials
8:16.04 - Antituberculosis Agents

Pyrazinamide

LASA

8:16.92 Antimycobacterials, Miscellaneous

Dapsone

25MG

Tablet

AUR

100MG

Tablet

AUR

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

100MG

Capsule

12 M.I.U.

Injection

30 MCG

Injection

6 M.I.U.

Injection

9.6 M.I.U.

Injection

75MG

Capsule

200MG

Tablet

200MG/5ML

Syrup

3%,4.5 GRAM

Eye
Ointment

STATUS

8:18 Antiviral
8:18.04 Adamantanes

Amantadine

8:18.20 Interferons

Interferon Beta-1a.

Interferon Beta-1b

8:18.28 Neuraminidase Inhibitors

Oseltamivir

8:18.32 Nucleosides and Nucleotides

Acyclovir

LASA

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

Acyclovir

400MG

Tablet

250Mg Powder
For Infusion

Vial

Famciclovir

250 MG

Tablet

AUR

Ganciclovir Vial

500 MG

Tablet

AUR

ValACYclovir

500MG

Tablet

LASA

Pyrimethamine

25MG

Tablet

Hydroxychloroquine

200MG

Tablet

500MG/100 ML

Injection

100MG

Tablet

25MG/5 ML, 60
ML

Syrup

STATUS

8:30 Antiprotozoals
8:30.08 - Antimalarials

8:30.04 - Amebicides

MetroNIDAZOLE

8:36 - Urinary Anti-infectives

Nitrofurantoin

LASA

8:00 - Anti-infective Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

500 MG

Vaginal
Suppository
Suspension

LASA

250MG

Tablet

LASA

500 MG

Tablet

LASA

8:30.92 Antiprotozoals, Miscellaneous

MetroNIDAZOLE

125MG/5ML
(120ML)

LASA

10. Antineoplastic Agents

10. Antineoplastic Agents

CLASS/DRUG

STRENGTH

FORM

Methotrexate

2.5 MG

Tablet

20MG

Pre-filled
syringe

Hydroxyurea Capsules

500 MG

Capsule

Interferon Beta 1a

12 M.I.U.

Injection

30 MCG

Injection

6 M.I.U.

Injection

Interferon Beta-1b

9.6 M.I.U.

Injection

Mitomycine-C

20MG

Vial

STATUS

AUR

12. Autonomic Drugs

12. Autonomic Drugs

CLASS/DRUG

STRENGTH

FORM

12:04. Parasymathomimetic (Cholinergic) Agents

2.5MG/ML

Ampoule

Neostigmine Methyl sulphate

0.5 MG/ML IN 1
ML

Ampoule

Physostigmine salicylate

2 MG

Ampoule

Neostigmine

12:08. Anticholinergic Agents

12:08.08 - Antimuscarinics/Antispasmodics

Atropine Sulfate

0.1MG/ML,
(10ML)

Pre-filled
syringe

Atropine Sulphate

0.1Mg/Ml (5Ml)

Atropine Sulfate

0.5MG

Prefilled
Syringe
Ampoule

Atropine Sulfate

1MG/ML

Ampoule

Glycopyrrolate

0.2 MG/ML

Vial

1MG

Tablet

Butylscopolamine (Hyoscine-N- 1MG/ML

Butyl Bromide)
10 MG

Tablet

20 MG/1 ML

Vial

Ipratropium Bromide ,Fenoterol 20 MCG/50

MCG
Hydrobromide
Ipratropium Bromide

Syrup

Metereddose inhaler

20MCG/PUFF

Inhaler

250MCG/2ML

Vial

500MCG/2ML

Ampoule

STATUS

12. Autonomic Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

12:12. Symapthomimetic (Adrenergic) Agents

12:12.04: alpha-Adrenergic Agonists

Phenylephrine

2.5% 5ML

Eye Drops

HAM

Injection

HAM

12:12.08 BETA ADRENERGIC AGONISTS

12:12.08.12 Selective Beta2-Adrenergic Agonists

Formoterol Fumarate
Dihydrate, Budesonide

4.5 MCG/160
MCG

Turbohaler

Salbutamol (Albuterol)

0.5%, 20 ML
100 MCG/PUFF

Nebulizer
Solution
Inhaler

500 MCG / ML

INJECTION

25 MCG, 250
MCG/PUFF

Evohaler

25 MCG, 50
MCG
50 MCG, 250
MCG
25 MCG, 125
MCG

Evohaler

Salmeterol xinafoate,
Fluticasone propionate

Diskus
Evohaler

12:12.08.08 Selective Beta1-Adrenergic Agonists

DOBUTamine

DOPamine HCl

500MG IN
250ML D5W
250 MG

Premixed
Bag
Injection

HAM, LASA

400MG, 250ML
D5W

Premixed
Bag

HAM, LASA

HAM, LASA

12. Autonomic Drugs

CLASS/DRUG

STRENGTH

FORM

DOPamine HCl

800MG, 250MG
D5W
40 MG/ML IN 5
ML (200 MG)

Premixed
Bag
Vial

HAM, LASA

Ampoule

HAM

Injection

HAM, LASA

AutoInjector

HAM, LASA

STATUS

HAM, LASA

12:12.08.04 Non-Selective Beta-Adrenergic Agonists

Isoprenaline HCL
(Isoproterenol)

200 MCG/ML

12:12.12 Alpha And Beta Adrenergic Agonists

EPINEPHrine
Epinephrine For Adult
Epinephrine (For Pediatrics
Anaphylactic Shock)
EPINEPHrine
ePHEDrine sulphate

1:1000(1MG/1
ML),1ML
0.3MG(1:1000)
150MCG

HAM, LASA

1:10000
(0.1MG/1ML),
10ML
50MG/ML - 1ML

Injection

HAM, LASA

Injection

HAM, LASA

30MG

Ampoule

HAM, LASA

12:16. Sympatholytic (Adrenergic Blocking) Agents

12:16.04. alpha-Adrenergic Blocking Agents
12:16.04.04. Non-selective alpha-Adrenergic Blocking Agents

Phentolamine

10MG/ML

Injection

12. Autonomic Drugs

CLASS/DRUG

STRENGTH

FORM

Ergotamine Tartrate, Caffeine

1 MG, 100 MG

Tablet

Norepinephrine (Noradrenaline) 1MG/ML, 4 ML

acid tartrate Injection

Ampoule

STATUS

HAM

12:16.04.08. Non-selective alpha-1-Adrenergic Blocking Agents

Terazosin

2MG

Tablet

12:16.04.12. Selective alpha-1-Adrenergic Blocking Agents

Tamsulosin MR

0.4 MG

Tablet

12:16.08. beta-Adrenergic Blocking Agents

12:16.08.04. Non-selective beta-Adrenergic Blocking Agents

Carvedilol

Propranolol

12.5MG

Tablet

LASA

25MG

Tablet

LASA

6.25MG

Tablet

LASA

1MG/ML

Injection

HAM

10MG

Tablet

40MG

Tablet

12. Autonomic Drugs

CLASS/DRUG

STRENGTH

FORM

Labetalol

100MG

Tablet

5MG/ML, 20ML

Injection

STATUS

HAM

12:16.08.08. Selective beta-Adrenergic Blocking Agents

100MG

Tablet

50MG

Tablet

25MG

Tablet

10MG

Tablet

5MG

Tablet

2.5MG

Tablet

Esmolol

10MG/ML,
10ML

Vial

Metoprolol

100MG

Tablet

1MG/ML, 5ML

Injection

50MG

Tablet

Atenolol

Bisoprolol

12:20. Skeletal Muscle Relaxants

12:20.04 CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS

TiZANidine

2MG

Tablet

4MG

Tablet

HAM

HAM

12. Autonomic Drugs

CLASS/DRUG

STRENGTH

FORM

Chlorzoxazone ,
Acetaminophen

250MG, 300MG

Capsule

12:20.08 DIRECT-ACTING SKELETAL MUSCLE RELAXANTS

Dantrolene Sodium

25MG

Capsule

20MG

Vial

12:20.12 GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS

Baclofen

10MG

Tablet

12:20.20: Neuromuscular Blocking Agents

Ampoule

Cisatracurium

10 MG/ML, 2.5
ML
2MG\ML

Pancuronium Bromide

2MG/ML

Ampoule

Rocuronium Bromide

10 MG/ML

Injection

Succinylcholine

100MG/2ML

Injection

Atracurium Besylate

Solution

STATUS

16:00 - Blood Derivatives

16:00 - Blood Derivatives

CLASS/DRUG

STRENGTH

FORM

Albumin Human

5%, 250ML

BAG

20%, 50ML

BOTTLE

STATUS

20:00 - Blood Formation, Coagulation, and Thrombosis

20:00 - Blood Formation, Coagulation, and Thrombosis

CLASS/DRUG

STRENGTH

FORM

Ferric hydroxide polymaltose

complex
Ferrous

50MG/5ml

Syrup

100MG

Tablet

Ferrous Salt (60-70 MG

Elemental iron)
Ferrous sulphate folic acid

200MG

Tablet

150MG, 0.5MG

Capsule

Ferrous sulphate

15MG/0.6ML
,50ML
100MG/5ML

Oral Drops

500MCG

Tablet

500MCG

Ampoule

1000 MCG/ML

Vial

1MG

Tablet

2.5MG

Tablet

2MG

Tablet

20:04 - Antianemia Drugs

20:04.04. Iron Preparations

Iron Saccharate

Injection

20:04.08. Liver and Stomach Preparations

Cyanocobalamin (B12)

20:12. Antithrombotic Agents

20:12.04. Anticoagulants
20:12.04.08. Coumarin Derivatives

Warfarin Sodium

STATUS

20:00 - Blood Formation, Coagulation, and Thrombosis

CLASS/DRUG

STRENGTH

FORM

Warfarin Sodium

3MG

Tablet

5MG

Tablet

100MG/ML

Vial

2.5MG/0.5ML

Syringe

5000 IU IN 0.2
ML
5000 IU/ML IN 5
ML
1000 I.U./ML,
5ML
20MG(2000IU)

Vial

HAM, LASA

Vial

HAM, LASA

Vial

HAM, LASA

STATUS

20:12.04.12 Direct Thrombin Inhibitors

Argatroban

LASA

20:12.04.14 Direct Factor Xa Inhibitors

Fondaparinux

20:12.04.16. Heparins

Heparin Sodium

Enoxaparin

40MG(4000IU)
60MG (6000IU)
80MG (8000IU)

Pre-filled
syringe
Pre-filled
syringe
Pre-filled
syringe
Pre-filled
syringe

20:00 - Blood Formation, Coagulation, and Thrombosis

CLASS/DRUG

STRENGTH

FORM

Aspirin (Acetylsalicylic Acid)

81MG-100MG

Tablet

Clopidogrel

75MG

Tablet

Alteplase (Rtpa)

50MG/50ML

Vial

Aspirin

81MG-100MG

tablet

Streptokinase

1,500000 I.U.

Vial

(1000) I.U.

Vial

(10000) I.U.

Vial

(2000 ) I.U.

Vial

(4000) I.U.

Vial

(40000) I.U.

Vial

20:12.18. Platelet-Aggregation Inhibitors

20:12.20. Thrombolytic Agents

20:16. Hematopoietic Agents

Recombinant human
erythropoietin

20:28. Antihemorrhagic Agents

20:28.08 - Antiheparin Agents

Protamine sulphate

Vial

STATUS

20:00 - Blood Formation, Coagulation, and Thrombosis

CLASS/DRUG

STRENGTH

FORM

0.5MG/1ML

Vial

500,000IU,
50ML

Vial

Aminocaproic acid

250 MG./ ML

Ampule

Antihemophilic factor VIIA

Human

LYOPHILIZED

STATUS

20:28.16 Hemostatics

Aprotinin

20:28.16 - Hemostatics

Antihemophilic Factor IX Human 500 IU

Vial

1000 IU

Vial

250 IU

Vial

500 IU

Vial

Anti-Rho(D) Immunoglobulin

(200-300 MCG)

Injection

Ethamsylate

250MG/2ML

Ampule

Tranexamic acid

500MG

Tablet

100MG/ML,
5ML

Injection

Antihemophilic Factor VIII

(Recombinant)

AUR

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

Injection

Quinidine sulphate

100MG/ML,
10ML
200 MG

Disopyramide (As Phosphate)

100-150 MG

Capsule

Lidocaine

1%

Injection

Lidocaine

4%

Lidocaine

1%

Lidocaine

2% 20MG/ML,
20ML

Topical
Solution
Pre-filled
syringe
Injection

STATUS

24:04 - Cardiac Drugs

24:04.04: Antiarrhythmic Agents
24:04.04.04. Class Ia Antiarrhythmics

Procainamide HCL

Tablet

24:04.04.08. Class Ib Antiarrhythmics

2%, 5ML

Lidocaine

2GM IN 500ML
D5W

Pre-filled
syringe
Premixed
Bag

Phenytoin

250MG/5ML

Injection

100MG

Tablet

50MG

Tablet

25MG

Tablet

24:04.04.16. Class II Antiarrhythmics

Atenolol

AUR

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

Bisoprolol

10MG

Tablet

5MG

Tablet

2.5MG

Tablet

10MG/ML,
10ML
100MG

Vial

1MG/ML, 5ML

Injection

50MG

Tablet

100MG

Tablet

5MG/ML, 20ML

Injection

150MG/3ML

Ampule

LASA

200MG

Tablet

LASA

500MG/10ML

Vial

Esmolol
Metoprolol

Labetalol

STATUS

HAM

Tablet
HAM

24:04.04.20. Class III Antiarrhythmics

Amiodarone

Bretylium Tosylate

24:04.04.24. Class IV Antiarrhythmics

Adenosine

6MG/2ML

Vial

Diltiazem Hcl

5MG/ML

Vial

Verapamil Hcl

5 MG/2 ML

Ampoule

HAM

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

24:04.04.92. Antiarrhythmics, Miscellaneous

Digoxin

500 MCG/2ML

Injection

0.05 MG./ ML.

IN 60 ML
0.0625MG

Elixer

0.125MG

Tablet

0.25MG

Tablet

500MCG/2ML

Injection

500MG IN
250ML D5W
500MG IN
250ML D5W
250 MG

Premixed
Bag
Premixed
Bag
Injection

HAM, LASA

400MG, 250ML
D5W
800MG, 250MG
D5W
40 MG/ML IN 5
ML (200 MG)
10MG/10ML

Premixed
Bag
Premixed
Bag
vial

HAM, LASA

145MG

Tablet

24:04.08. Cardiotonic Agents

Digoxin (PAEDIATRIC)
Digoxin

DOBUTamine

DOBUTamine HCL
DOPamine HCl

Milrinone

Tablet

Injection

24:06 - Antilipemic Agents

24:06.06 Fibric Acid Derivatives

Fenofibrate

HAM, LASA
HAM, LASA

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

10MG

Tablet

LASA

20MG

Tablet

LASA

40MG

Tablet

LASA

10MG

Tablet

LASA

20MG

Tablet

LASA

40MG

Tablet

LASA

100MG

Tablet

5MG/ML, 20ML

Injection

100MG

Tablet

50MG

Tablet

25MG

Tablet

10MG/ML,
10ML
100MG

Vial

24:06.08 - HMG-CoA Reductase Inhibitors

SIMVAstatin

ATORVAstatin

24:08 - Hypotensive Agents

24:08.04 - -Adrenergic Blocking Agents

Labetalol

24:08.08 - -Adrenergic Blocking Agents

Atenolol

Esmolol
Metoprolol

Tablet

1MG/ML, 5ML

Injection

CLASS/DRUG

STRENGTH

FORM

Metoprolol

50MG

Tablet

Labetalol

100MG

Tablet

5MG/ML, 20ML

Injection

HAM

24:00 - Cardiovascular Drugs

STATUS

24:08.12 - Calcium-Channel Blocking Agents

AmLODIPine

5MG

Capsule

LASA

AmLODIPine Besylate

10MG

Capsule

LASA

Nicardipine

25MG/10ML

Ampoule

NIFEdipine Retard

20MG

Tablet

LASA

NIFEdipine LA

30MG

Tablet

LASA

60Mg

Tablet

LASA

24:08.12.92 Calcium-Channel Blocking Agents, Miscellaneous

30MG

Tablet

60MG

Tablet

90MG

Tablet

Diltiazem Hcl

5MG/ML

Injection

Verapamil

40MG

Tablet

Diltiazem

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

Verapamil Hcl

5MG/2ML

Ampoule

CloNIDine HCL

100MCG

Tablet

LASA, AUR

CloNIDine HCL

150MCG

Tablet

LASA, AUR

CloNIDine HCL

150MCG/ML

Vial

LASA, AUR

Methyldopa

250MG

Tablet

20MG/1ML

Vial

HAM, LASA

25MG

Tablet

HAM, LASA

2 % (60ML)

Solution

5 % (60ML)

Solution

50MG

Injection

STATUS

HAM

24:08.16 - Central -Agonists

24:08.20 - Direct Vasodilators

HydrALAZINE

Minoxidil

Nitroprusside

24:08.24 - Diuretics (Cardiovascular Drugs)

24:08.24.08 Loop Diuretics

Furosemide Syrup
Furosemide

1MG/ML, 100
ML
20MG/2ML

Syrup

40MG

Tablet

Ampule

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

24:08.24.12 Osmotic Diuretics (Cardiovascular Drugs)

Mannitol

10% 500Ml

Bottle

20% 500Ml

Bottle

24:08.24.16 Potassium Sparing Diurectics (Cardiovascular Drugs)

AMILoride, Hydrochlorothiazide 5MG, 50MG

Spironolactone

Tablet

100MG

Tablet

25MG

Tablet

24:08.24.20 Thiazide Diuretics (Cardiovascular Drugs)

Hydrochlorothiazide

25MG

Tablet

24:08.24.24 Thiazide-like Diuretics (Cardiovascular Drugs)

Indapamide

1.5MG

Tablet

Metolazone

5MG

Tablet

24:08.24.92 Diuretics, Miscellaneous (Cardiovascular Drugs)

Theophylline

200MG

Tablet

Theophylline Hydrate

60MG/5ML,300
ML

Liquid

LASA

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

24:08.44. Renin-Angiotensin-Aldosterone System Inhibitors

24:08.44.04 Angiotensin-Converting Enzyme Inhibitors

Enalapril

Perindopril

10MG

Tablet

20MG

Tablet

5MG

Tablet

5MG

Tablet

24:08.44.08. Angiotensin II Receptor Antagonists

Candesartan

Irbesartan

Losartan

Valsartan

16 MG

Tablet

8 MG

Tablet

150 MG

Tablet

300 MG

Tablet

100MG

Tablet

50MG

Tablet

160 MG

Tablet

80 MG

Tablet

Valsartan, Hydrochlorothiazide 160MG, 12.5MG

80MG, 12.5MG

Tablet
Tablet

24:08.44.20. Mineralocorticoid (Aldosterone) Receptor Antagonists

Spironolactone

100MG

Tablet

25MG

Tablet

STATUS

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

20MG

Tablet

5MG
50MG

Subligual
Tablet
Vial

25MG/10CM

Patch

0.5MG

Subligual
Tablet

STATUS

24:12 - Vasodilating Agents

24:12.08. Nitrates and Nitrites

Isosorbide Dinitrate

Nitroglycerin

24:12.12 Phosphodiesterase Type 5 Inhibitors

Sildenafil

50Mg

Tablet

24:12.92. Vasodilating Agents, Miscellaneous

Ampoule

Bosentan

0.5 MG/ML IN 1
ML
125 Mg

Papaverine

30mg/ml

Injection

Diltiazem

30MG

Tablet

60MG

Tablet

90MG

Tablet

Diltiazem Hcl

5MG/ML

Injection

Verapamil

40MG

Tablet

Verapamil Hcl

5MG/2ML

Ampoule

Alprostadil (PGE1) Paediatric

Tablet

AUR

HAM

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

24:20 - -Adrenergic Blocking Agents

Terazosin

2MG

Tablet

Carvedilol

12.5MG

Tablet

LASA

25MG

Tablet

LASA

6.25MG

Tablet

LASA

100MG

Tablet

5MG/ML, 20ML

Injection

Labetalol

24:24 - -Adrenergic Blocking Agents

Propranolol

Atenolol

Bisoprolol

Carvedilol

1MG/ML

Injection

HAM

10MG

Tablet

40MG

Tablet

100MG

Tablet

50MG

Tablet

25MG

Tablet

10MG

Tablet

2.5MG

Tablet

5MG

Tablet

12.5MG

Tablet

LASA

25MG

Tablet

LASA

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

Carvedilol

6.25MG

Tablet

LASA

Esmolol

10MG/ML,
10ML
100MG

Vial

1MG/ML, 5ML

Injection

50MG

Tablet

100MG

Tablet

5MG/ML, 20ML

Injection

Metoprolol

Labetalol

Bisoprolol, Hydrochlorothiazide 5MG, 12.5MG

Tablet
HAM

Tablet

24:28 - Calcium-Channel Blocking Agents

24:28.08. Dihydropyridines

AmLODIPine

5MG

Tablet

LASA

AmLODIPine besylate

10MG

Capsule

LASA

Nicardipine

25MG/10ML

Ampoule

NIFEdipine Retard

20MG

Tablet

LASA

NIFEdipine LA

30MG

Tablet

LASA

60MG

Tablet

LASA

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

24:28.92. Calcium-Channel Blocking Agents, Miscellaneous

30MG

Tablet

60MG

Tablet

90MG

Tablet

Diltiazem Hcl

5MG/ML

Injection

Verapamil

40MG

Tablet

Verapamil Hcl

5 MG/2 ML

Ampoule

Diltiazem

HAM

24:32 - Renin-Angiotensin-Aldosterone System Inhibitors

24:32.04. Angiotensin-Converting Enzyme (ACE) Inhibitors

Captopril

Enalapril

Lisinopril

Perindopril

25MG/5ML,
100ML
25MG

Suspension

LASA

Tablet

LASA

50MG

Tablet

LASA

10MG

Tablet

20MG

Tablet

5MG

Tablet

5MG

Tablet

10MG

Tablet

20MG

Tablet

5MG

Tablet

24:00 - Cardiovascular Drugs

CLASS/DRUG

STRENGTH

FORM

24:32.08. Angiotensin II Receptor Antagonists

Candesartan

Irbesartan

Losartan

Valsartan

16MG

Tablet

8MG

Tablet

150MG

Tablet

300MG

Tablet

100MG

Tablet

50MG

Tablet

160MG

Tablet

80MG

Tablet

Valsartan, Hydrochlorothiazide 160MG, 12.5MG

80MG, 12.5MG

Tablet
Tablet

24:32.20. Mineralocorticoid (Aldosterone) Receptor Antagonists

Spironolactone

100MG

Tablet

25MG

Tablet

STATUS

28. Central Nervous System Agents

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

500
MG/Ampoule

Injection

Desflurane

250 ML

Bottle

Sevoflurane

250 ML

Bottle

STATUS

28:04: General Anesthetics

28:04.04. Barbiturates

Thiopental Sodium
28:04.16 Inhalational Anesthetics

HAM

28:04.92. General Anesthetics, Miscellaneous

Etomidate

2MG/ML, 10ML

Vial

Etomidate

2MG/ML, 20ML

Vial

Ketamine

50MG/ML

Injection

Propofol

1 % 10 MG/ML
IN 20 ML

Injection

HAM

1% 10MG/ML
50 ML

Injection

HAM

2% 50ML Vial

Injection

HAM

28:04 Analgesics and Antipyretics

28:08.04 Nonsteroidal Anti- Inflammatory Agents
28:08.04.08. Cyclooxygenase-2 (COX-2) Inhibitors

Celecoxib

200MG

Capsule

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

81MG-100MG

Tablet

STATUS

28:08.04.24. Salicylates

Aspirin

28:08.04.92. Other Nonsteroidal Anti-inflammatory Agents

Diclofenac

Diclofenac Sodium

100MG

Tablet

12.5MG

Suppository

50MG

Tablet

1%

Gel

100MG

Suppository

15MG/3ML

Ampule
Patch

Diclofenac Epolamine
100MG/5ML,
100ML

Syrup

400MG

Tablet

Ibuprofen Lysine

15mg/ML

Vial

Indomethacin

100MG

Suppository

25MG

Capsule

1 MG/Vial

Injection

50 MG/Vial

Injection

250MG

Capsule

Ibuprofen

Mefenamic Acid

AUR

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

Meloxicam

15MG

Tablet

7.5MG

Tablet

30MG 1ML

Vial

300/30 mg

Tablet

Ketorolac

STATUS

LASA

28:08.08 Opiate Agonists

Acetaminophen-Codeine

Acetaminophen (Paracetamol), 120MG,

12MG/5ML
Codeine

Syrup

Alfentanil

0.5MG

Ampoule

Codeine

30MG

Tablet

FentaNYL

100MCG

Ampule

LASA

25MCG

LASA

50MCG/ML,2ML

Dermal
patches
Dermal
patches
Dermal
patches
vial

10MG/5ML

Syrup

LASA

10MG

Tablet

LASA

50MCG
100MCG

Morphine Sulphate

LASA
LASA
LASA

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

Morphine Sulphate

30MG

S.R. Tablet

LASA

5MG/ML

Injection

LASA

10Mg/Ml,1Ml

Ampoule

LASA

Methadone

5MG

Tablet

LASA

oxyCODONE

5MG

Tablet

LASA

Pethidine (Meperidine)

100MG/2ML

Injection

50MG/1ML

Injection

2MG

Vial

5MG

Vial

Sufentanil

0.05MG

Ampoule

TraMADol

100MG

Tablet

50MG

Tablet

50MG/2ML

Injection

100MG

Suppository

20MG

Ampoule

Remifentanil

28:08.12 Opiate Partial Agonists

Nalbuphine

STATUS

LASA

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

28:08.92 Analgesics and Antipyretics, Miscellaneous

Acetaminophen (Paracetamol) 10 MG/ML 100

Acetaminophen (Paracetamol),
Codeine
Chlorzoxazone,
Acetaminophen (Paracetamol)
Gabapentin

Vial

ML (1GM)
500mg

Vial

125MG

Suppository

250MG

Suppository

350MG

Suppository

500MG

Suppository

500MG

Tablet

120MG/5 ML

Syrup

120mg/5ml

Oral Drops

120MG/12MG
/5ML
250 mg /
300mg
300MG

Syrup

400MG

Capsule

0.02MG/ML

Injection

0.4MG/ML

Injection

Capsule
Capsule

28:10. Opiate Antagonists

Naloxone

STATUS

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

30MG/10ML,
500ML

Syrup

10MG

Tablet

100MG

Tablet

200MG/ML

Injection

20MG/5ML

Bottle

STATUS

28:12 ANTICONVULSANTS
28:12.04 Barbiturates, Anticonvulsants

Phenobarbitone

28:12.08 Anticonvulsants - Benzodiazepines

ALPRAZolam

ClonazePAM

Diazepam

0.25MG

Tablet

C, LASA

0.5MG

Tablet

C, LASA

0.5MG

Tablet

C, LASA

2MG

Tablet

C, LASA

2.5MG/ML,10M
L
2MG

Drops

C, LASA

Tablet

5MG

Tablet

10MG

Tablet

10MG/2ML

Ampule

2MG/5ML

Syrup

5 MG/TUBE

Rectal
solution

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

Midazolam

2MG/ML

Injection

5MG/ML

Injection

1MG

Tablet

C, LASA

2MG

Injection

C, LASA

100MG

Capsule

250MG/5ML

Injection

30MG/5ML

Syrup

250MG

Capsule

50MG/ML

Syrup

200MG

Tablet

LASA

400MG

Tablet CR

LASA

100 MG/5 ML
100 ML

Syrup

LASA

LORazepam

STATUS

28:12.12 Anticonvulsants - Hydantoins

Phenytoin

28:12.20 Succinimides

Ethosuximide

AUR

28:12.92 Miscellaneous Anticonvulsants

CarBAMazepine

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

Gabapentin

300MG

Capsule

400MG

Capsule

100MG

Tablet

LASA

50MG

Tablet

LASA

100MG

Syrup

LASA

500MG

Tablet

LASA

Magnesium Sulphate

500MG/ML
(50%), 5Ml

Ampoule

Pregabalin

150MG

Capsule

75MG

Capsule

100MG

Tablet

15MG

Capsule

25MG

Tablet

200MG

Tablet

500MG

Tablet SR

200MG/ML
250 MG/5ML

Oral
solution
Syrup

400MG/4ML

Injection

LamoTRIgine

LevETIRAcetam

Topiramate

Valproate sodium

STATUS

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

28:16. Psychotherapeutic Agents

28:16.04 Antidepressants
28:16.04.20. Selective Serotonin-reuptake Inhibitors

Escitalopram

10MG

Tablet

PARoxetine

20 MG

Tablet

LASA

28:16.04.28. Tricyclics and Other Norepinephrine-reuptake Inhibitors

Amitriptyline HCL

10MG

Tablet

25 MG

Tablet

50MG

28:16.08 Antipsychotic Agents

28:16.08.04 Atypical Antipsychotics

Clozapine

100MG

Tablet

AUR

OLANZapine

10MG

Tablet

AUR

5MG

Tablet

AUR

100MG

Tablet

LASA

300MG

Tablet

LASA

2MG

Tablet

AUR

4MG

Tablet

AUR

QUEtiapine

RisperiDONE

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

1.5MG

Tablet

5MG

Tablet

2MG/ML,15ML

Drops

5MG/ML

vial

STATUS

28:16.08.08 Butyrophenones

Haloperidol

28:20. Anorexigenic Agents and Respiratory and CNS Stimulants

28:20.32. Respiratory and CNS Stimulants

Doxapram
Methylphenidate

20MG/ML,
20ML
10MG

Vial

18MG

Tablet

36MG

Tablet

Tablet

28:20.92 Anorexigenic Agents and Respiratory and Cerebral Stimulants,Miscellaneous

Caffeine Citrate

20MG/ML, 3ML
20 MG/ML, 3ML

Oral
Solution
Vial

28:24. Anxiolytics, Sedatives, and Hypnotics

28:24.04. Barbiturates

PHENobarbital

30MG/10ML,
500ML

Syrup

C, LASA

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

PHENobarbital

10MG

Tablet

C, LASA

100MG

Tablet

C, LASA

200MG/ML

Injection

C, LASA

20MG/5ML

Bottle

C, LASA

0.25MG

Tablet

C, LASA

0.5MG

Tablet

C, LASA

Clobazam

10MG

Tablet

LASA

chlordiazePOXIDE

5MG

Tablet

LASA

ClonazePAM

0.5MG

Tablet

C, LASA

2MG

Tablet

C, LASA

2.5MG/ML

Drops

C, LASA

10MG

Tablet

10MG/2ML

Injection

2MG

Tablet

2MG/5ML

Syrup

5MG

Tablet

5 MG/TUBE

Rectal tube

28:24.08. Benzodiazepines

ALPRAZolam

Diazepam

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

LORazepam

1MG

Tablet

C, LASA

2MG

Injection

C, LASA

2MG/ML

Injection

5MG/ML

Injection

Midazolam

28:24.92. Anxiolytics, Sedatives, and Hypnotics; Miscellaneous

500MG/5ML

Syrup

40MG

Bottle

hydrOXYzine

10MG

Tablet

Promethazine

25MG/ML, 2ML

Injection

Propofol

1 % 10 MG/ML
IN 20 ML
1% 10MG/ML
50 ML
2%, 50ML

Injection

HAM

Injection

HAM

Injection

HAM

10MG

Tablet

200MG

Tablet

LASA

400MG

Tablet CR

LASA

100 MG/5 ML
100 ML

Syrup

LASA

Chloral Hydrate

Zolpidem

LASA

28:28. Antimanic Agents

CarBAMazepine

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

Valpoate sodium

200MG

Tablet

500MG

Tablet SR

200MG/ML

Oral drops

250 MG/5ML

Syrup

400MG/4ML

Injection

50MG

Tablet

STATUS

28:32. Antimigraine Agents

28:32.28. Selective Serotonin Agonists

SUMAtriptan

28:32.92. Antimigraine Agents, Miscellaneous

Ergotamine Tartrate , Caffeine

1 MG, 100 MG

Tablet

Propranolol

10MG

Tablet

40MG

Tablet

100MG

Tablet

15MG

Capsule

25MG

Tablet

Topiramate

LASA

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

Valproate sodium

200MG

Tablet

500MG

Tablet SR

200MG/ML
250 MG/5ML

Oral
solution
Syrup

100MG

Capsule

Benztropine

1MG/ML IN 2 ML

Injection

Benztropine MESYLATE

2MG

Tablet

Trihexyphenidyl

2MG

Tablet

5MG

Tablet

STATUS

28:36. Antiparkinsonian Agents

28:36.04. Adamantanes

Amantadine

28:36.08. Anticholinergic Agents

28:36.12. Catechol-O-Methyltransferase (COMT) Inhibitors

Levodopa, Carbidopa, and

Entacapone

200MG, 50MG,
200MG

Tablet

LASA

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

100MG, 25MG

Tablet

200MG, 50MG

Tablet

250MG, 25MG

Tablet

200MG, 50MG,
200MG
50MG, 12.5MG,
200MG

Tablet

STATUS

28:36.16. Dopamine Precursors

Carbidopa, Levodopa

Levodopa, Carbidopa, and

Entacapone

Tablet

28:36.20. Dopamine Receptor Agonists

28:36.20.04 Ergot-derivative Dopamine Receptor Agonists

Bromocriptine

2.5MG

Tablet

Cabergoline

500MCG

Tablet

150MG

Capsule

75MG

Capsule

28:40. Fibromyalgia Agents

Pregabalin

28. Central Nervous System Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

28:92. Central Nervous System Agents, Miscellaneous

Flumazenil

0.5MG/5ML

Ampule

32:00 Contraceptives (Foams, devices, etc)

Desogestrel

75 MCG

Tablet

LASA

36: Diagnostic Agents

CLASS/DRUG

STRENGTH

FORM

10% 500Ml

Bottle

20% 500Ml

Bottle

10MG/ML

Injection

2.5MG/ML

Ampoule

0.5 MG/ML IN 1
ML

Ampoule

Fluorescein and Lidocaine

4% , 0.25%

Eye drops

Flourescein

0.25%

Minims

Trypan Blue Ophthalmic

Solution (Intraocular Capsule

0.6MG/ML

Solution

5 tuberculin
units / 0.1ml -1
ml

Injection

STATUS

36:40 Kidney Function

Mannitol

36:56. Myasthenia Gravis

Edrophonium Chloride
Neostigmine
Neostigmine Methyl sulphate

36:58 Ocular Disorders

36:84. Tuberculosis
Tuberculin (PPD) Skin Tests

LASA

36: Diagnostic Agents

CLASS/DRUG

STRENGTH

FORM

Barium Sulfate For Ugi

98%

Suspension

Barium-Based Contrast Media

For Enteroclysis

50% W/V

Kit

36:68 Contrast Media

20Ml
Gadopentetic Acid
(Magnevist), Non-Ionic, For MRI

Iobitridol, Non-Ionic, For Ct

Scan

300Mg/Ml 50Ml

Barium Sulfate Suspension For 1.3% W/V (400

Ml)
Ct Examinations Of The
Gastrointestinal Tract

Injection
Injection
Enema Kit
W/ Barium
Sulfate
Suspension

Barium Sulfate Suspension For

Computed Tomography Of
Gastrointestinal Tract

1.3-1.5% W/V
(450 Ml )

Suspension

Barium Sulfate Suspension For

Double Contrast Colon
Examinations

105% W/V
(1900
Ml/Gallon)

Suspension

Sodium Diatrizoate
(Gastrografin)

120ML

bottle

Sodium Amidotrizoate,
Meglumine Amidotrizoate
(Urografin)

146Mg/Ml 30%
250Ml.

Injection

STATUS

40. Electrolytic, Caloric, and Water Balance

CLASS/DRUG

STRENGTH

FORM

5MEQ/ML, IN 20
ML
500ML

Solution for
injection
Bottle

Sodium Bicarbonate

1 KG

Jar

Sodium Acetate

1 MEQ/ML, 10
ML
2MEQ/ML
20ML, 4
MEQ/ML
325MG 50ML

Prefilled
syringe
Vial

Syringe

Potassium Citrate (Urocit K)

8.4%
[1MMOL/1ML]
50ML
10meq/tablet

Ringer's Lactate

1000ML

Bag

Ringer's Lactate IV

500ML

Bag

Lactulose

3.35GM/5ML

Syrup

Sodium Benzoate

500 GM

Oral powder

40:04: Acidifying Agents

Ammonium chloride
Ringer's Lactate

40:08. Alkalinizing Agents

Tablet

Tablet

40:10. Ammonia Detoxicants

STATUS

40. Electrolytic, Caloric, and Water Balance

CLASS/DRUG

STRENGTH

FORM

40:12. Replacement Preparations

Tablet

Calcium and Vitamin D

Calcium Carbonate

600MG

Tablet

Calcium Chloride

0.9% IV (10ML)

Vial

10% (10 ML)

10%

Prefilled
syringe
Vial

Calcium Gluconate

10% 10ML

Ampoule

Calcium Gluconate + Calcium

Glubionate

1.2 G/5ML

Syrup
Powder

Calcium polystyrene
sulphonate (Calcium Resonium
Powder)
Dextran LMW

500ml

Bottle

Hydroxyethyl starch penta

starch

6% 500 ML

Solution

Oral rehydration electrolyte

Sachet

Oral rehydration electrolyte

Solution
Ampoule

Magnesium Hydroxide

500MG/ML
(50%), 5Ml
50%, 4
mEq/ML, 50ML
1200MG

Potassium Chloride

600MG

Tablet

Magnesium Sulphate
Magnesium Sulfate Kit

Vial
Syrup

STATUS

40. Electrolytic, Caloric, and Water Balance

CLASS/DRUG

STRENGTH

FORM

Potassium Chloride

2MEQ/ML,
10ML
120ML

Injection

Potassium Phosphate for TPN

4.4 MMOL/ML

Injection

Potassium Phosphate

45Mm/15ml +
66 mEq/15

Injection

Sodium polystyrene sulfonate

454G

Powder

Sodium Glycerophosphatel
(Glycophos)

1Mmol P /Ml
,20ML

Vial

Sodium Phosphate

45 mMol/15 ml

Injection

Sodium Phenyl Acetate, Sodium 10%, 10 %

Benzoate

Syrup

Ampoule

Phosphate Sandoz

500MG

Tablet

Sodium Chloride

0.9% 30ML

Nasal spray

0.9% 100 ML

Bag

0.9% 50 ML

Bag

0.9 % 500 ML

Bag

0.9% 500ML

Bag

0.9%
(1000ML)
0.9% (100ML)

Bag

0.9% 250ML

Bag

Sodium Chloride

STATUS

Bag

AUR

AUR

40. Electrolytic, Caloric, and Water Balance

CLASS/DRUG

STRENGTH

FORM

Sodium Chloride

0.45%
(500ML)
0.45% IV
(1000ML)
14.60%

Bag

3% 500Ml

Bottle

50 % 12.5
G/AMPOULE,
25ML
1000ML

Ampoule

10ML

Ampoule

Sodium Chloride Hypertonic

solution
Sodium Thiosulfate
Sterile water for injection

Bag
Solution

Bag

40:18. Ion-removing Agents

40:18.18. Potassium-removing Agents
Powder

Calcium polystyrene
sulphonate (Calcium Resonium
Powder)
Sodium polystyrene sulfonate

454G

Powder

100MG/ML,
500ML
600MG

Syrup

10% (10 ML)

10%

Prefilled
syringe
Vial

10% 10ML

Ampoule

40:18.19. Phosphate-removing Agents

Calcium Carbonate

Calcium Chloride

Calcium Gluconate

Tablet

STATUS

40. Electrolytic, Caloric, and Water Balance

CLASS/DRUG

STRENGTH

FORM

Amino Acids crystalline

Injection (Essential and 7 at
Amino Acids crystalline
Injection (Essential and 7 at
L-Carnitine

15% IN
HYPERTONIC
Solution
10%
IN 100ML
HYPERTONIC
Solution
100ML
200 MG/ML

Solution

Fat Emulsion (MCT/LCT)

300MG/ML, (20
ML)
20% 500ML

Oral
Solution
Vial

Dextrose

5% 100 ML

Bag

5% 50ML

Bag

10%, 500ML

Bag

50%, 50ML

Vial

5%, 0.225%
(500ML)
10%

Solution

5%, 0.45%
(500 ML)
5%, 500 ML

Solution

5%, 500 ML

Bag

10%, 500ML

Bag

40:20: Caloric Agents

Dextrose, normal saline

Dextrose In Normal Saline
Dextrose, Sodium Chloride
Dextrose Solution, normal
saline
Dextrose
Dextrose IV 500 ML Bag

Solution
Injection

Solution

Solution

STATUS

40. Electrolytic, Caloric, and Water Balance

CLASS/DRUG

STRENGTH

FORM

STATUS

250MG

Tablet

LASA

500 MG/Vial

Injection

LASA

1MG/ML, 100
ML
20MG/2ML

Syrup

40MG

Tablet

10% 500Ml

Bottle

20% 500Ml

Bottle

AMILoride

5MG

Tablet

Spironolactone

100MG

Tablet

25MG

Tablet

25 MG

Tablet

40:28. Diuretics
40:28.04. Carbonic Anhydrase Inhibitors

AcetaZOLAMIDE

40:28.08. Loop Diuretics

Furosemide

Injection

40:28.12 Osmotic Diuretics

Mannitol

40:28.16. Potassium-sparing Diuretics

40:28.20. Thiazide Diuretics

Hydrochlorothiazide

LASA

40. Electrolytic, Caloric, and Water Balance

CLASS/DRUG

STRENGTH

FORM

1.5MG

Tablet

Theophylline

200MG

Tablet

Theophylline Hydrate

60MG/5ML,300
ML

Liquid

Bag Solution

Glycine Powder

1.5% IN
3000ML
1 Kg

Sodium Chloride

0.45% 500ML

Bottle

0.90%

Bottle

0.45% IV
(1000ML)
1000 ML

Bag

STATUS

40:28.24. Thiazide-like Diuretics

Indapamide

40:28.92. Diuretics, Miscellaneous

40:36. Irrigating Solutions

Glycine Solution

Sodium Chloride Soution

Sterile Water for Irrigation

Bottle

Bottle

AUR

44. Enzymes
CLASS/DRUG

STRENGTH

FORM

Alteplase (Rtpa)

50MG/50ML

Injection

Streptokinase

1,500000 I.U.

Vial

STATUS

48:00 Respiratory Tract Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

48:04. Antihistamines (Respiratory Tract)

48:04.04 First Generation Antihistamines(Respiratory Tract)

DiphenhydrAMINE (Systemic)

50MG/ML, 1ML

Vial

LASA

25MG

Capsule

LASA

48:04.08 Second Generation Antihistamines (Respiratory Tract)

1.25MG,
30MG/5ML

Syrup

Guaifenesin,
Dextromethorphan

118ML

Syrup

Dextromethorphan

15MG/5ML

Syrup

Triprolidine, Pseudoephedrine

48:08. Antitussives

DiphenhydrAMINE, Ammonium 14MG, 135MG,

1.1MG
chloride, Menthol
DiphenhydrAMINE, Menthol

7MG, 0.55MG

Syrup

LASA

Syrup

LASA

48:10. Anti-inflammatory Agents(Respiratory Tract)

48:10.08. Corticosteroids (Respiratory Tract)
48:10.08.04. Nasal Preparations

Fluticasone propionate

50MCG

LASA

Nasal spray

48:00 Respiratory Tract Agents

CLASS/DRUG

STRENGTH

FORM

Mometasone Furoate

0.05%

Nasal spray

48:10.08.08. Orally Inhaled Preparations

Budesonide, Formoterol
Budesonide

160 MCG/4.5
MCG
200MCG/PUFF

Turbohaler

250 MCG/ML
2ML
500MCG/ML

Nebulizer

10MG

Tablet

4MG

Chewable
Tablet
Chewable
Tablet

Turbohaler

NEBULIZER

48:10.24. Leukotriene Modifiers

Montelukast

5MG

48:12. Bronchodilators
48:12.04. Adrenergic Agents (Respiratory Tract)
48:12.04.12. Selective beta-2-Adrenergic Agonists (Respiratory Tract)

Salbutamol (Albuterol)

100MCG, (200
DOSES)

Inhaler

STATUS

48:00 Respiratory Tract Agents

CLASS/DRUG

STRENGTH

FORM

Salbutamol (Albuterol)

0.5% IN 20ML

Nebulizer
Solution
INJECTION

500 MCG / ML

Formoterol Fumarate
Dihydrate, Budesonide

4.5 MCG/160
MCG

STATUS

Turbohaler

48:12.04.16. alpha- and beta-Adrenergic Agonists (Respiratory Tract)

ePHEDrine Sulphate

50MG/ML - 1ML

Vial

HAM, LASA

EPINEPHrine

1:1000(1MG/1
ML),1ML
1:10000
(0.1MG/1ML),
10ML

Ampule

HAM, LASA

Ampule

HAM, LASA

48:12.08. Anticholinergic Agents(Respiratory Tract)

Atropine Sulphate
Atropine Sulphate

Ipratropium bromide

0.1MG/ML,
(10ML)
0.1Mg/Ml (5Ml)
0.5MG

Prefilled
syringe
Prefilled
Syringe
Ampule

1MG/ML

Ampule

20MCG/PUFF

Inhaler

250MCG/2ML

Vial

500MCG/2ML

Solution
Ampule
Metred dose
Inhaler

Ipratropium bromide, Fenoterol 20 MCG, 50 MCG

Hydrobromide

48:00 Respiratory Tract Agents

CLASS/DRUG

STRENGTH

FORM

Theophylline

200MG

Tablet

Theophylline Hydrate

60MG/5ML

Liquid

Aminophylline

250MG/10ML

Vial

Guaifenesin,
Dextromethorphan

118ML

Syrup

DiphenhydrAMINE,Ammonium
chloride, Menthol

14MG, 135MG,
1.1MG

Syrup

DiphenhydrAMINE, Menthol

7MG, 0.55MG

Syrup

200MG/ML,
10ML
4MG/5ML

Ampoule

Bosentan

125 Mg

Tablet

Sildenafil

50Mg

Tablet

48:12.12. Xanthine Derivatives

48:16. Expectorants

48:24. Mucolytic Agents

Acetylcysteine
Bromhexine Hcl

Syrup

48:48: Vasodilating Agents

STATUS

48:00 Respiratory Tract Agents

CLASS/DRUG

STRENGTH

FORM

Iloprost

10MCG/ML

Injection

20MCG/ML
(1ML)

solution

25mg/ml

Vial

48:36 Pulmonary Surfactants

Beractant (Survanta)

48:92 Respiratory Tract Agents, Miscellaneous

Omalizumab

150 MG

Vial

Racemic EPINEPHrine

2.25 %, 15ML

Solution

STATUS

52:00 - Eye, Ear, Nose, and Throat (EENT) Preparations

CLASS/DRUG

STRENGTH

FORM

5 ML

Eye Drops

Chloramphenicol

0.5%,10ML

Eye drops

Chloramphenicol

1%

Erythromycin

0.50% 3.5G

Fusidic acid ophthalmic

1%

Fucidic Acid

1% 5GM

Eye
Ointment
Eye
Ointment
Eye viscous
drops
Eye drops

Gatifloxacin

0.3% 5ML

Eye drops

Gentamicin minims

0.30%

Eye drops

Moxifloxacin

0.50%

Eye drops

STATUS

52:02 Antiallergic Agents

Ketotifen

52:04. Anti-infectives
52:04.04. Antibacterials

Neomycin, gramicidin, nystatin, 2.5mg/0.25mg

/100000u/
triamcinolone

Eye drops

Neomycin, Polymyxin B, and

Dexamethasone

Eye drops

Ofloxacin

1mg/g.

0.3%, 5
ML/BOTTLE

Polymyxin B ,Neomycin
Tobramycin

0.3% , 3.5Gm

Eye drops
Ophthalmic
Solution
Eye
Ointment

LASA

52:00 - Eye, Ear, Nose, and Throat (EENT) Preparations

CLASS/DRUG

STRENGTH

FORM

100,000
I.U./ML

Suspension

STATUS

52:04.16. Antifungals

Nystatin

52:04.92. Anti-infectives, Miscellaneous

Chlorhexidine gluconate sodium 0.2 % IN 150 -

Mouth wash

Silver Nitrate Cautery

Cautery

200
ML/BOTTLE

52:08. Anti-inflammatory Agents

52:08.08. Corticosteroids
160MCG/4.5MC
G
0.5MG/GM
(0.05%) 3 GM

Turbohaler

Dexamethasone, Ofloxacin

3.1 /MG

Eye drops

Fluorometholone (FML)

0.10% 5ML

Eye drops

Fluticasone propionate

50 MCG

Inhaler

125MCG

Inhaler

250 MCG

Inhaler

Fluticasone propionate

50MCG

Nasal spray

Hydrocortisone Sodium
Succinate

100MG

Ampoule

Mometasone Furoate

0.05%

Nasal spray

Budesonide, formoterol
dexamethasone ophth

Eye
Ointment

LASA

52:00 - Eye, Ear, Nose, and Throat (EENT) Preparations

CLASS/DRUG

STRENGTH

FORM

PrednisoLONE

1%

Eye drops

Triamcinolone

40MG /ML

Intraocular

52:08.20 Nonsteroidal Anti-inflammatory Agents (EENT)

0.1% 0.3ML

Eye drops

2%

Minims

0.25%

Minims

0.40%

Minims

Atropine ophth

1% (10ML)

Eye drops

Cyclopentolate Hcl

1 % 10-15 ML

Eye drops

1%

Minims

0.10%

Minims

Diclofenac Sodium

52:16. Local Anesthetics

Fluorescein

Benoxinate (Oxybuprocaine)

52:24. Mydriatics

Tropicamide

STATUS

52:00 - Eye, Ear, Nose, and Throat (EENT) Preparations

CLASS/DRUG

STRENGTH

FORM

52:28. Mouthwashes and Gargles

Chlorhexidine gluconate sodium 0.2 % IN 150 -

Mouth wash

200
ML/BOTTLE

52:32. Vasoconstrictors
Naphazoline, chlorpheniramine 0.05,0.05%
maleate
0.025,0.3%
Naphazoline, pheneramine
maleate
100MG
Xylometazolin
Xylometazolin for adult
for children

Nasal drops
Eye drops
Nasal drops

1MG

Nasal drops

0.5MG

Nasal drops

0.15% 5ML

Eye drops

52:40. Antiglaucoma Agents

52:40.04 Alpha Adrenergic Agonist

Brimonidine

52:40.08: beta-Adrenergic Blocking Agents

Timolol preservative free

0.25%

Eye drops

STATUS

52:00 - Eye, Ear, Nose, and Throat (EENT) Preparations

CLASS/DRUG

STRENGTH

FORM

Timolol preservative free

1% 5ML

Eye drops

STATUS

52:40.12 Carbonic Anhydrase Inhibitors

Brinzolamide Preservative Free 1% 5ML

Drops
2% (5 ML)
Dorzolamide

Eye drops

2%, 0.5%

Eye drops

Carbachol

0.01%.

Intraocular

Acetylcholine Chloride
Intraoccular

1%

Intraocular

Mannitol

10% 500 ML

Bottel

Sorbitol-Mannitol Irrigation

3000ML

Bag

Latanoprost

0.01%

Eye drops

Latanoprost, Timolol Maleate

50MCG, 5MG

Eye drops

Dorzolamide, Timolol

Eye drops

52:40.20: Miotics

52:40.24 Osmotic Agents (EENT)

52:40.28 Prostaglandin Analogs

AUR

52:00 - Eye, Ear, Nose, and Throat (EENT) Preparations

CLASS/DRUG

STRENGTH

FORM

Balanced Salt Solution (Bss)

500ML

Solution

Docusate sodium

0.5% w/v

Ear drops

Carboxymethyl Cellulose
(Refresh Plus)

0.5%, 0.4ML

Minims

White Petrolatum, Mineral Oil

(Refresh P.m)

57.3%, 42.5%

Ointment

Polyacrylic Acid

20MG

Eye Gel tube

Sodium Chloride

0.9% 30ML

Nasal spray

Hydroxypropyl methyl
cellulose, Dextran (Tears
Naturale)

0.3%,0.1%

Eye drops

52:92. EENT Drugs, Miscellaneous

STATUS

56.00 Gastrointestinal Drugs

CLASS/DRUG

STRENGTH

FORM

250MG - 300MG

Tablet

56:04. Antacids and Adsorbents

Activated Charcoal

Powder

Aluminum Hydroxide,
Magnesium Hydroxide

Magnesium oxide

405MG +
100MG/5ML

Suspension

400 MG/100
MG

Tablet

400 MG

Tablet

2MG

Tablet

56:08. Antidiarrhea Agents

Loperamide

56:10. Antiflatulents
Tablet

Simethicone Anti-flatulent

56:12. Cathartics and Laxatives

Bisacodyl

10MG

Suppository

5MG

Suppository

5MG

Tablet

STATUS

56.00 Gastrointestinal Drugs

CLASS/DRUG

STRENGTH

FORM

Castor Oil

60ML

Bottle

Docusate Sodium

100MG

Capsule

Fleet Enema Adult

135ML

Enema

60ML

Enema

Pedia

Liquid

Glycerin
Glycerin Pediatric
Adult
Lactulose

900MG

Suppository

1.8GM
3.35GM/5ML

Syrup

Milk Of Magnesia Concentrated 1200 MG/15ML

Bottle

Polyethylene Glycol-Electrolyte
Bowel preparation (MoviPrep)

Sachet

Polyethylene Glycol-Electrolyte
laxatives (Movicol)

Sachet

Psyllium Fiber Supplement

(Orange Flavor)

174G

Bottle

Senna

12MG

Tablet

Sodium Phosphate as
Phosphate

3MEQ/ML, 15
ML

STATUS

56.00 Gastrointestinal Drugs

CLASS/DRUG

STRENGTH

FORM

300MG

Capsule

30ML

Syrup

4MG

Ampoule

4MG

Tablet

1MG/ML

Ampoule

Promethazine

25MG/ML, 2ML

Injection

Hyoscine-N-Butylbromide

10 MG

Tablet

20 MG/1 ML

Ampoule

1MG/ML

Syrup

56:14. Cholelitholytic Agents

Ursodeoxycholic acid

56:20. Emetics
Ipecacuanha

56:22. Antiemetics
56:22.20 5-HT3 Receptor Antagonists

Ondansetron

Granisetron

56:22.92 Antiemetics, Miscellaneous

Meclizine hydrochloride,
pyridoxine hydrochloride

Tablet

STATUS

56.00 Gastrointestinal Drugs

CLASS/DRUG

STRENGTH

FORM

STATUS

56:28. Antiulcer Agents and Acid Suppressants

56:28.12. Histamine H2-Antagonists

Ranitidine HCL

150MG

Tablet

50MG

Injection

200MCG

Tablet

100MCG

Tablet

10MG

Tablet

LASA

20MG

Tablet

LASA

40MG

Injection

LASA

20MG

Tablet

40MG

Tablet

40MG

Vial

10MG

Tablet

4MG/ML,15ML

Drops

5MG/5ML

Syrup

10 MG/2 ML

Ampoule

56:28.28. Prostaglandins

Misoprostol

56:28.36. Proton-pump Inhibitors

Omeprazole

Esomeprazole

56:32. Prokinetic Agents

Metoclopramide

56.00 Gastrointestinal Drugs

CLASS/DRUG

STRENGTH

FORM

800mg

Tablet

2GM

Sachet

1GM

Suppository

500MG

Tablet

10MG

Tablet

5MG/5ML

Suspension

200MG

Capsule

135MG

Tablet

STATUS

56:36. Anti-inflammatory Agents

Mesalazine (Mesalamine)

SulfaSALAzine

56:40 GI Drugs, Miscellaneous

Domperidone

56:92. GI Drugs, Miscellaneous

Mebeverine

LASA

64:00 - Heavy Metal Antagonists

CLASS/DRUG

STRENGTH

FORM

Deferoxamine

500MG/VIAL

Vial

Deferasirox

125 MG

Tablet

STATUS

68:00 - Hormones and Synthetic Substitutes

CLASS/DRUG

STRENGTH

FORM

STATUS

160 MCG/4.5
MCG
200MCG/PUFF

Turbohaler

250 MCG/ML
2ML

Nebulizer

500MCG/ML

Nebulizer

Fludrocortisone Acetate

100MCG

Tablet

Hydrocortisone

50MG/ML

Vial

25MG

Suppository

10 MG

Tablet

Hydrocortisone Sodium
Succinate

100MG

Ampoule

MethylPREDNISolone acetate
(Depo-Medrol )

40MG

Vial

LASA

MethylPREDNISolone sodium
succinate (Solu-Medrol)

500MG

Injection

LASA

PrednisoLONE

20MG

Tablet

5MG

Tablet

15MG/5 ML

Syrup

Tramcinolone acetonide

40 MG/ML

Vial

Dexamethasone

4MG

Tablet

Dexamethasone

4MG

Ampoule

68:04. Adrenals
Budesonide, formoterol
Budesonide

Turbohaler

68:00 - Hormones and Synthetic Substitutes

CLASS/DRUG

STRENGTH

FORM

Dexamethasone

8MG/2ml

Ampoule

2MG/0.035MG

Tablet

68:12. Contraceptives

Cyproterone Acetate +
Ethinylestradiol

Ethinyl Estradiol, Drospirenone 1MG, 2MG

Desogestrel, Ethinyl estradiol
Dydrogesterone
MedroxyPROGESTERone
Acetate

Tablet

0.15 MG + 0.03
MG
10MG

Tablet

500MG

Tablet

150MG/ML

Vial

Tablet

Non-Hormonal Intrauterine
Contraceptive Device (Nova-T)

Device

Hormonal LevonorgestrelReleasing Intrauterine Device

(Mirena)

Device

68:16: Estrogens and Estrogen Agonists-Antagonists

68:16.04: Estrogens

Conjugated Estrogens

0.625MG

Tablet

1.25 MG

Tablet

STATUS

68:00 - Hormones and Synthetic Substitutes

CLASS/DRUG

STRENGTH

FORM

Conjugated Estrogens

0.625MG/GM

Vaginal
cream

ClomiPHENE

50mg

Tablet

Desogestrel+Ethinyl estradiol

0.15 MG + 0.03
MG
25MCG

Tablet

Estradiol

STATUS

LASA

Vaginal
Pessary

68:18 Gonadotropins

Human Chorionic
Gonadotrophin
Human Menopausal
Gonadotrophin
Leuprorelin

5000 I.U

Vial

75 I.U

Injection

3.75MG

Injection

7.5MG

Injection

100MG

Tablet

50MG

Tablet

500MG

Tablet

LASA

850MG

Tablet

LASA

68:20. Antidiabetic Agents

68:20.02. alpha-Glucosidase Inhibitors

Acarbose

68:20.04. Biguanides

MetFORMIN

68:00 - Hormones and Synthetic Substitutes

CLASS/DRUG

STRENGTH

FORM

STATUS

68:20.05 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Sitagliptin

100MG

Tablet

100
UNITS/ML,3ML
100 U/ML, 3ML

Penfill
cartridge
Pre-filled
pen
Pre-filled
pen
Vial

68:20.08. Insulins

Insulin (NPH/SOL.) 30/70

Insulin Aspart Solution

(NovoRapid FlexPen.)
Insulin Glargine ,Solution
(Lantus)
Insulin Human Isophane
soluble(70/30)
Insulin Human Isophane
Suspension
Insulin Human Regular
Insulin soluble Human pen
Insulin aspart

100 U/ML, 3ML

10ML
100 UNITS/ML
IN 10 ML
100 UNITS/ML
IN 10 ML
100 IU/ML 3ML
100 UNITS/ ML,
10 ML

Vial
Vial
Pre-filled
pen
Vial

68:20.20. Sulfonylureas

Glibenclamide (GlyBURIDE)

5MG

Tablet

Gliclazide MR

30 MG

Tablet

Glimepiride

1MG

Tablet

2MG

Tablet

3MG

Tablet

LASA

68:00 - Hormones and Synthetic Substitutes

CLASS/DRUG

STRENGTH

FORM

STATUS

68:20.28. Thiazolidinediones

Pioglitazone

15MG

Tablet

30MG

Tablet

68:20.92. Antidiabetic Agents, Miscellaneous

2.5MG

Tablet

Glucagon

1MG/ML

Vial

Diazoxide

50MG/ML

Suspension

100UNITS/ML,
2ML

Ampule

Vasopressin

20 UNITS/ML

Vial

Desmopressin Acetate Melt

60MCG

Tablet

Bromocriptine

68:22. Antihypoglycemic Agents

68:22.12 Glycogenolytic Agents

AUR

68:24. Parathyroid
Calcitonin

68:28. Pituitary

68:00 - Hormones and Synthetic Substitutes

CLASS/DRUG

STRENGTH

FORM

STATUS

Desmopressin Acetate

4MCG/ML

Injection

68:36. Thyroid and Antithyroid Agents

68:36.04. Thyroid Agents
25MCG

Tablet

50 MCG

Tablet

100 MCG

Tablet

5MG

Tablet

Hydroxyprogesterone
Caproate
Progesterone

250MG/ML

Vial

400MG

Norethisterone (Primolut-N)

5 MG

Vaginal
Pessary
Tablet

Thyroxine sodium
(Levothyroxine)

68:36.08. Antithyroid Agents

Carbimazole

68:32 Progestins

72:00 - Local Anesthetics

CLASS/DRUG

STRENGTH

FORM

STATUS

Lidocaine, EPINEPHrine
Lidocaine, EPINEPHrine
Lidocaine (Topical)

Lidocaine (Systemic)

1%, 1:100,000
, 20ML
2%, 1:80000,
1.8 Ml
2% (20G)

Injection

10MG/SPRAY

Aerosol

1% 10 MG/ML,
20 ML
2% 20MG/ML,
20ML
2%, 5ML

Injection

Injection
Gel tube

Injection
Prefilled
syringe
Cream

Bupivacaine Heavy

2.5 %, 2.5%
(5G)
0.5%, 4ML

Bupivacaine

0.25% (20ML)

Vial

0.5%, 20 ML

Injection

5MG/ML
DEXTROSE 8%
(4 ML)
0.5%,
1:200,000
2MG/ML

Ampoule

Lidocaine, Prilocaine

Bupivacaine in Dextrose
Bupivacaine With Epinephrine
Injection
Ropivacaine

AUR

Vial

Injection
Injection

AUR

76:00 Oxytocics
CLASS/DRUG

STRENGTH

FORM

STATUS

Carboprost Tromethamine

250mcg/ml

Vaginal
Insert
Vaginal
Insert
Ampoule

Methylergometrine Maleate

0.2 MG/ML

Ampoule

Oxytocin

10 UNITS/1ML

Injection

Oxytocin and Ergometrine

5 UNITS,
0.5MG/1ML
5 IU/ML IN 1ML

Injection

Dinoprostone E3

3MG
10MG

Oxytocin Synthetic

Ampoule

80. Serums, Toxoids, and Vaccines

CLASS/DRUG

STRENGTH

FORM

STATUS

80:04. Serums
Antivenin Scorpion (SCORPION 1ML
VENOM ANTISERUM)
Antivenin Snake (ANTIVENIN) 10ML

Injection

Human ANTI-D Immune Globulin 1500 IU (300

Injection

Human normal Immune Globulin 5 % I.V. 2.5

Injection

Digoxin Immune Fab

(ANTIDIGOXIN FAB

GM/50 ML
40MG/Vial

Injection

0.5ML

Vial

0.5 ML

Vial

0.5 ML

Vial

Injection

MCG)

80:08. Toxoids
Diphtheria,Tetanus , Acellular
Pertussis (DTaP), Toxoid
Diphtheria,Tetanus, Pertussis
Toxoid
Tetanus Toxoid

80:12. Vaccines
Vial

Hepatitis A Vaccine
(for Adolescents and adults )
Hepatitis A Vaccine
(for children)
Hepatitis B Vaccine
(for Adolescents and adults )

Vial
Vial

80. Serums, Toxoids, and Vaccines

CLASS/DRUG

Hepatitis B Vaccine
(for children)

STRENGTH

FORM

Vial

STATUS

(Hexa Vaccine) Diphtheria,

Hemophilus Influenzae B,
Measles Virus Vaccine
Measles, Mumps, and Rubella
(MMR) Vaccine
Meningococcal Vaccine
Meningococcal and Diphtheria
Conjugate Vaccine
Pneumococcal Vaccine 13
valent
Polio virus Vaccine oral (OPV)

0.5ML

Syringe

0.5 ML

Vial

0.5ML

Vial

50MCG/0.5 ML

Vial
Vial

0.5 ML

Vial

0.5 ML

Vial

Rabies Virus Vaccine

0.5 ML

Vial

Varicella- zoster virus

(Chickenpox vaccine)
BCG Vaccine

0.5 ML

Vial

Diphtheria Tetanus Vaccine

0.5 ML

Vial

Penta Vaccine (DPT+Hepatitis

B, hib vaccine)
Influenza Virus Vaccine

0.5ML

Injection

Polio virus Vaccine S.C. (IPV)

AUR

Vial

Vial

LASA

80. Serums, Toxoids, and Vaccines

CLASS/DRUG

STRENGTH

FORM

Vial

Rubella Vaccine
Typhoid Vaccine

0.5 ML

Vial

Yellow Fever Vaccine

0.5 ML

Vial

Rotavirus Vaccine

1ML

Vial

Measles, Mumps, Rubella And

Varicella (Mmrv-Vaccine)

0.5ML

Vial

STATUS

84. Skin and Mucous Membrane Agents

CLASS/DRUG

STRENGTH

FORM

Fusidate SOD. Skin

2 % 15 GM

Ointment

Fusidic Acid

2 % 30 GM

Cream

Fusidic Acid , Hydrocortisone

acetate
Mupirocin

2%, 1% (30 GM)

Cream

2 % (15 GM)

Ointment

Nystatin, Neomycin,
Gramcidine, Triamcinolone

(100000 U,
2.5MG, 0.25MG
, 1GM)

Cream Or
Ointment

84:04 Anti-infectives
84:04.04. Antibacterials

STATUS

MetroNIDAZOLE

0.75%

Gel

1%

Cream

100MG

Vaginal
pessary
Vaginal
Tablet
Vaginal
Cream
Cream

AUR, LASA

84:04.08. Antifungals

84:04.08.08 Azoles
Clotrimazole

0.5G
500MG

Miconazole, Hydrocortisone

2%, 1% (30 GM)

Miconazole

2%, 45 GM
2%

Vaginal
Cream
Cream

2%, 40G

Oral gel

84. Skin and Mucous Membrane Agents

CLASS/DRUG

STRENGTH

FORM

Miconazole

400MG

Ketoconazole

2%, 120ML

Vaginal
ovule
Shampoo

2% (20MG/GM)
30GM

Cream

Crotamiton

10% IN 30 GM

Cream

Pyrethrin anti Lice

50ML Bottle

Shampoo

84:04.12. Scabicides and Pediculicides

STATUS

Permethrin

5 % (30-60
Gm)

Cream

AUR

84:04.92. Local Anti-infectives, Miscellaneous

Silver Sulfadiazine (Flamazine) 1%, 50G

Povidone-Iodine

Cream

5%10GM

Ointment

5% w/v Sterile
30ML

Ophthalmic
Solution

0.05 % (30 GM)

Ointment

15GM

Ointment

0.05%, 2 % IN
30ML
0.05% + 3%
15Gm

Scalp lotion

84:06: Anti-inflammatory Agents

Betamethasone Dipropionate

Betamethasone Dipropionate,
Salicylic Acid

Ointment

84. Skin and Mucous Membrane Agents

CLASS/DRUG

STRENGTH

FORM

Betamethasone Valerate

0.1 % (30 GM)

Cream

Clobetasol Propionate

0.05% (25G )

Cream

Hydrocortisone

1%

Cream

Hydrocortisone Butyrate
Lipocream
Mometasone Furoate

0.1%.

Cream

0.1% 30GM

Cream

0.10%

lotion

0.10%

Ointment

0.1 % (15-30
GM)

Ointment

Triamcinolone Acetonide

STATUS

AUR

40MG/ML

Vial

84:08: Antipruritics and Local Anesthetics

Calamine Lotion

lotion

Dimethindene Maleate

Gel

84:12 Astringents
Aluminum Chloride

20%

Solution

AUR

84:16 Cell Stimulants and Proliferants (Skin and Mucous Membrane)

Tretinoin ( Retin A)

0.05%

Cream

LASA

STATUS

84. Skin and Mucous Membrane Agents

CLASS/DRUG

STRENGTH

FORM

Tretinoin ( Retin A)

0.025%.

Gel

LASA

84:24 Emollients, Demulcents, and Protectants (Skin and Mucous Membrane)

84:24.12 Basic Ointments and Protectants (Skin and Mucous Membrane)

Panthenol (Dexpanthenol)

84:28: Keratolytic Agents

5%

Ointment

5%

Cream

Salicylic acid, lactic acid

Salicylic Acid

16.7%, 16.7 %
(15-30 ML)
10 % (30 G)

Cutaneous
solution
Ointment

2 % (15-30 ML)

Topicalscalp

20% (30 G)

Ointment

40%

Patch

5 % (30 G)

Ointment

84:50: Depigmenting and Pigmenting Agents

84:50.04 Depigmenting Agents

Fluocinolone, Hydroquinone ,
Tretinoin
Hydroquinone

0.01%, 4%,
0.05%
4% (30 G TUBE)

Cream

LASA

Cream

84. Skin and Mucous Membrane Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

84:92: Skin and Mucous Membrane Agents, Miscellaneous

Adapalene

0.10%

Gel

B-Sitosterol

0.25% W/W 30
GM
50 MCG/GM

Ointment

50 Mcg, 0.5 Mg

Ointment

10MG

Capsule

LASA

20MG

Capsule

LASA

5%

Cream

Calcipotriol
Calcipotriol, Betamethasone
Dipropionate
ISOtretinoin

Imiquimod

Onimtment

Lanolin

50G in 100G

Ointment
Cream

Lipobase Cream QV
5%

Cream

5%

Ointment

Pimecrolimus

1% 30G

Cream

Tacrolimus

0.03% 30G

Ointment

0.1% 30G

Ointment

15-15.25 %,
B.P IN 30 GM

Cream

Panthenol, Dexpanthenol 5%

Zinc Oxide

86:00 Smooth Muscle Relaxants

CLASS/DRUG

STRENGTH

FORM

86:12 Smooth Muscle Relaxants, Genitourinary

Oxybutynin Chloride

5MG/5ML

Syrup

Solifenacin

5MG

Tablet

Tolterodine

2MG

Tablet

4MG

Tablet
Oral
suspension

86:16 Smooth Muscle Relaxants, Respiratory

STATUS

Aminophylline

250MG/10ML

Vial

Theophylline

200MG

Tablet

Theophylline Hydrate

60MG/5ML,300
ML
50Mg

Liquid

Sildenafil

Tablet

88:00 Vitamins
CLASS/DRUG

STRENGTH

FORM

50000 /IU

Capsule

500MCG

Tablet

500MCG

Ampoule

1000 MCG/ML

Vial

5MG

Tablet

STATUS

88:04 VITAMINE A
Vitamin A Water Missible

88:08. Vitamin B Complex

Cyanocobalamin (B12)

Folic Acid

LASA

1MG

Tablet

Pyridoxine (Vitamin B6)

40MG

Tablet

Riboflavin (Vitamin B2)

20MG

Tablet

50MG

Tablet

100MG

Tablet

Biotin

10 Mg

Tablet

Thiamine

100 MG/1 ML

Ampoule

Vitamin B Complex
Combination (B1 + B6 + B12)
Vitamin B1(100Mg) + B6
(100Mg) + B12(1Mg)

LASA

AUR

Tablet
50.000 I.U.

Ampoule

STRENGTH

FORM

500MG

Tablet

Alfacalcidol (Vitamin D3
analog)

0.25 MCG

Capsule

1 MCG

Capsule

Calcitriol

0.25MCG

Capsule

2MCG/ML

Ampoule

88:00 Vitamins
CLASS/DRUG

88:12. Vitamin C
Ascorbic Acid (Vitamin C)

88:16. Vitamin D

STATUS

Cholecalciferol (VIT D3)

5000 IU

Capsule

2000IU

Capsule

1000IU

Capsule

50000 IU

Capsule

2,800 IU/ML
(15ML )
4500 IU

Oral Drops
Oral Drops
Tablet

Calcium and Vitamin D

88:00 Vitamins
CLASS/DRUG

STRENGTH

FORM

10MG

Tablet

2 MG/0.2 ML

Ampoule IM
Injection
Aqueous
solution

88:24. Vitamin K Activity

Phytomenadione (K1)

10 MG/ML

88:28. Multivitamin Preparations

Fat soluble vitamins

Ampoule

Multivitamin

Adult.

Injection

Ped.

Injection

STATUS

Oral drops
Syrup
Tablet

Multivitamin and Minerals

Tablet

Maternal Multivitamin And

Minerals (Materna)

Tablet

92:00 - Miscellaneous Therapeutic Agents

CLASS/DRUG

STRENGTH

FORM

92:08: 5-alpha-Reductase Inhibitors

Finasteride

5MG

Film coated
Tablet

200MG/ML,
10ML
250MG - 300MG

Ampoule

92:12: Antidotes
Acetylcysteine
Activated Charcoal

Tablet
Powder

Atropine Sulphate

0.1MG/ML,
(10ML)

Prefilled
syringe

STATUS

1MG/ML

Prefilled
Syringe
Ampoule

Atropine Sulphate

0.5MG

Ampoule

Calcium Choride

10% (10 ML)

10%

Prefilled
syringe
Vial

Calcium Disodium Edetate

1GM/AMPOULE

Vial

Calcium Gluconate

10% 10ML

Ampoule

Cyanide Poison Antidote Kit

5GM

Vial

Dantrolene Sodium

20MG

Vial

Deferoxamine

500MG/VIAL

Vial

Atropine Sulphate

0.1Mg/Ml (5Ml)

92:00 - Miscellaneous Therapeutic Agents

CLASS/DRUG

STRENGTH

FORM

Digoxin Immune Fab

40MG/VIAL

Injection

Magnesium Sulphate

Ampoule

Fat emulsion (MCT/LCT)

500MG/ML
(50%), 5Ml
50%, 4
mEq/ML, 50ML
20% 500ML

Flumazenil

0.5MG/5ML

Ampule

Glucagon

1MG/ML

Vial

L-Carnitine

200 MG/ML

Injection

Methylene blue

10ML

Vial

Magnesium Sulfate Kit

STATUS

Vial
Vial
LASA
AUR

0.02MG/ML

Injection

0.4MG/ML

Injection

Physostigmine Salicylate

2 MG

Ampoule

Pralidoxime

1GM

Injection

Naloxone

Injection

Protamine Sulfate
Pyridoxine (Vitamin B6)

40MG

Tablet

Scorpion antivenin (Scorpion

Venom Antiserum)
Snake Antivenin (Antivenin)

1ML

Injection

10ML

Injection

Sodium Bicarbonate

8.40%

Vial

4.20%

Vial

50 % 12.5
G/AMPOULE

Ampoule

Sodium Thiosulfate

92:00 - Miscellaneous Therapeutic Agents

CLASS/DRUG

STRENGTH

FORM

Thiamine Hcl

100 MG/1 ML

Ampoule

Vitamin Phytomenadione (K1)

10MG

Tablet

100MG

Tablet

300MG

Tablet

0.6MG

Tablet

92:16: Antigout Agents

Allopurinol

Colchicine

STATUS

100MG

Suppository

25MG

Capsule

1 MG/Vial

Injection

50 MG/Vial

Injection

Adalimumab

40 MG/0.8 ML

AzaTHIOprine

50MG

Prefilled
syringe
Tablet

Etanercept Solution

50MG/ML

Interferon Beta-1a.

12 M.I.U.

Indomethacin

92:20. Biologic Response Modifiers

LASA

Autoinjector
Injection

92:00 - Miscellaneous Therapeutic Agents

CLASS/DRUG

STRENGTH

FORM

Interferon Beta-1a.

30 MCG

Injection

6 M.I.U.

Injection

9.6 M.I.U.

Injection

Alendronate

70MG

Tablet

Calcitonin

100UNITS/ML,
2ML

Injection

Interferon Beta-1b

92:24: Bone Resorption Inhibitors

STATUS

92:36: Disease-modifying Antirheumatic Drugs

Adalimumab

40 MG/0.8 ML

AzaTHIOprine

50MG

Etanercept Solution

50MG/ML

Hydroxychloroquine

200MG

Autoinjector
Tablet

Methotrexate

2.5 MG

Tablet

20MG

Prefilled
syringe
Tablet

SulfaSALAzine

500MG

Prefilled
syringe
Tablet

LASA

92:00 - Miscellaneous Therapeutic Agents

CLASS/DRUG

STRENGTH

FORM

STATUS

AzaTHIOprine

50MG

Tablet

LASA

Methotrexate

2.5 MG

Tablet

Methotrexate

20MG

Prefilled
syringe

92:44: Immunosuppressive Agents

92:92: Other Miscellaneous Therapeutic Agents

botulinum toxin A

100 UNITS

Vial

Racemic EPINEPHrine

2.25 %, 15ML

Solution

LASA

Trace Element For Adult

Vial

Trace Element for Pediatrics

Injection

Betahistine Dihydrochloride

16MG

Tablet

8MG

Tablet

Tribenoside, Lidocaine (Procto- 30GM

Glyvenol)

Cream

(400mg, 40mg)

Suppository

Zinc Sulphate

30MG

Tablet

Povidone iodine

5% w/v Sterile
30ML
10GM , 15GM

Ophthalmic
solution
Tube

Tribenoside, lidocaine

400MG + 40MG

Suppository

5%+ 2%

Cream

92:00 - Miscellaneous Therapeutic Agents

CLASS/DRUG

STRENGTH

Zinc Oxide 300Mg, Peru Balsam 300Mg, 50Mg,

33Mg
,Benzyl Benzoate
0.10%
Xylometazoline

FORM

Suppository
Spray

Sodium Chloride

0.9 /%

Eye drops

Ethanolamine Oleate Injection

5%

Injection

Hexylresorcinol Blackcurrant
lozenges (Strepsils )
Hyaluronic acid

2% 10ML

Eye drops

Hexylresorcinol Blackcurrant
lozenges
Hyaluronate And Derivatives
(Provisc/ Discovisc)

lozenges
1% 0.85ML

STATUS

Injection

Micronized Purified Flavonoid

Fraction of Diosmin and

500mg

Tablet

94:00 Devices
CLASS/DRUG

STRENGTH

FORM

Dextranomer/Hyaluronic Acid
Copolymer (Deflux)

50MG/ML,
15MG/ML

Injection

STATUS

96:00 Pharmaceutical Aids

96:00 Pharmaceutical Aids

CLASS/DRUG

Surgical Lubricant Jelly

Jelly)
White Petroleum Jelly
(Vaseline)
Ora-Plus
Simple Syrup or (Ora-Sweet)
Blephaclean Eye Pads

STRENGTH

FORM

Jelly

(K100Gm

Jelly

473ml

Bottle

473ml

Bottle
Eye pads

STATUS